Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the
amount on which the filing fee is calculated and state how it was determined):

(4)

Proposed maximum aggregate value of transaction:

(5)

Total fee paid:

$

¨

Fee paid previously with preliminary materials.

¨

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing
for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

Elect two Class I directors listed in the accompanying Proxy Statement and recommended by our Board of
Directors to serve for a term of three years, or until their respective successors have been duly elected and qualified;

2.

Hold an advisory vote to approve the compensation paid to our named executive officers;

3.

Ratify the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinets independent registered public
accounting firm for Fabrinets fiscal year ending June 30, 2017; and

4.

Transact such other business as may properly come before the meeting, or any adjournment or postponement
thereof.

These items of business are more fully described in the proxy statement accompanying this
notice. Any action on the items of business described above may be considered at Fabrinets 2016 Annual Meeting of Shareholders (the Annual Meeting) at the time and on the date specified above, or at any time and date to which
the meeting may be properly adjourned or postponed.

Record Date

Only shareholders of record at the close of business on October 17, 2016, are entitled to notice of and to vote at the Annual
Meeting, and at any postponements or adjournments of the meeting.

Voting

Your vote is very important. Even if you plan to attend the Annual Meeting in person, we encourage you to read the
proxy statement and to vote as quickly as possible, to ensure your vote is recorded. For specific instructions on how to vote your shares, please follow the procedures outlined in your Notice of Internet Availability of Proxy Materials, or
refer to the section of the proxy statement entitled Questions and Answers About the Annual Meeting and Procedural Matters.

Thank you for your ongoing support of Fabrinet.

By order of the Board of Directors,

/s/ David T. Mitchell

David
T. Mitchell

Chief Executive Officer and Chairman of the Board of Directors

Grand Cayman, Cayman Islands

October 21, 2016

Important Notice Regarding the Availability of Proxy
Materials for the Annual Meeting of Shareholders to Be Held on Thursday, December 15, 2016

The proxy statement and 2016 Annual Report to Shareholders are available at www.proxyvote.com.

Shareholders as of the record date are entitled to vote. Each ordinary share is entitled to one vote for each
director nominee and one vote for each of the other matters properly presented at the Annual Meeting. At the close of business on the record date, there were 36,778,321 ordinary shares outstanding and entitled to vote at the Annual
Meeting.

Admission to Meeting:

You are invited to attend the Annual Meeting if you were a shareholder of record or a beneficial owner as of the record
date. You should bring photo identification for entrance to the Annual Meeting. The meeting will begin promptly at 9:00 a.m., Pacific time, and you should leave ample time for the check-in procedures. Shareholders may request
directions to the offices of Wilson Sonsini Goodrich & Rosati by calling (650) 493-9300.

Matters to Be Voted on at the Annual Meeting

Matter

BoardRecommendation

Page Reference forMore Information

Proposal 1:

Election of two Class I directors

FOR each nominee

Page 10

Proposal 2:

Annual advisory vote to approve named executive officer compensation

FOR

Page 15

Proposal 3:

Ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinets independent auditor for fiscal 2017

FOR

Page 16

Business and Financial Highlights

Fiscal 2016 capped another year of significant growth for Fabrinet, driven by a combination of momentum in the optical industry, growing
contributions from new customers, and increasing demand for our advanced packaging and precision assembly capabilities. For fiscal 2016, we reported record annual revenue of approximately $976.7 million, an increase of 26% from fiscal
2015. The following table illustrates our fiscal 2016 results in terms of revenue, net income, net income per diluted share and fiscal-end closing share price relative to fiscal 2015:

Please see the section titled Managements Discussion and Analysis of Financial Condition and
Results of Operations in our Annual Report on Form 10-K for the year ended June 24, 2016 (filed with the Securities and Exchange Commission on August 17, 2016), for a more detailed discussion of our fiscal 2016 financial results.

(2)

Please refer to Annex A for a reconciliation of this non-GAAP financial measure to the most directly
comparable financial measure calculated in accordance with generally accepted accounting principles in the United States (GAAP).

In addition, we established Fabrinet West, Inc. as a new product introduction (NPI) center in the heart of Silicon Valley and
began construction of a new manufacturing facility at our campus in Chonburi, Thailand. Fabrinet West serves as a business development arm with an emphasis on new business generation and eventual transfer of the manufacturing process to
Thailand after NPI. Equipped with state-of-the-art surface mount and advanced optical packaging technologies and infrastructure, and with close proximity to a large portion of our customer base, this center helps to accelerate customer NPI and
provides seamless access and future transfer to our low-cost manufacturing base in Thailand.

Executive Compensation Program Highlights

Our executive compensation program is designed to be heavily weighted towards compensating our executives
based on company performance. To that end, we have implemented executive compensation policies and practices that reinforce our pay-for-performance philosophy and align with commonly viewed best practices and sound governance principles. The
following chart summarizes these policies and practices:

More than half of the total compensation (60% for CEO, 57% for COO and 54% for CFO) was variable and
performance-based, and a substantial portion (60% for CEO, 38% for COO and 47% for CFO) was equity-based.



Challenging performance goals established at the beginning of fiscal 2016 determined payouts under cash- and
equity-based incentive compensation plans following the completion of fiscal 2016.



A mix of long-term and short-term compensation components align executive interests with shareholders and
serve to attract, retain and motivate executives.

Fiscal 2017 Updates.As discussed in
more detail in the section titled Executive CompensationCompensation Discussion and Analysis, approximately 28% of the votes cast at our 2015 annual meeting of shareholders were in favor of the advisory vote on executive
compensation. Taking into account the results of such advisory vote and feedback received from shareholders during 2016, the Compensation Committee made the following changes to our fiscal 2017 executive compensation program:

Increased the annual base salaries of our CEO (by 29%), COO (by 20%) and CFO (by 20%), following a fiscal year
in which they had not received raises;



Increased the target, but decreased the maximum, amount that may become payable to each of our executive
officers under our fiscal 2017 cash-based incentive plan;



Amended agreements with our CEO, COO and CFO to limit vesting acceleration provisions to equity-based awards
granted prior to August 2016 (except for restricted share units granted in August 2016 that were based on fiscal 2016 performance);

This proxy statement is being provided to holders of ordinary shares of Fabrinet at the close of business on the record date (October 17,
2016) in connection with the solicitation of proxies by Fabrinets Board of Directors for use at Fabrinets 2016 Annual Meeting of Shareholders, and any postponements, adjournments or continuations thereof (the Annual Meeting),
for the purpose of considering and acting upon the matters set forth in this proxy statement and the accompanying notice. The Annual Meeting will be held on Thursday, December 15, 2016, at the offices of Wilson Sonsini Goodrich & Rosati, 650
Page Mill Road, Palo Alto, California 94304, commencing at 9:00 a.m., Pacific time.

QUESTIONS AND ANSWERS
ABOUT THE ANNUAL MEETING AND PROCEDURAL MATTERS

Q:

Can I attend the Annual Meeting?

A:

You are invited to attend the Annual Meeting if you were a shareholder of record or a beneficial owner as of
October 17, 2016 (the Record Date). You should bring photo identification for entrance to the Annual Meeting. The meeting will begin promptly at 9:00 a.m., Pacific time, and you should leave ample time for the check-in
procedures. Shareholders may request directions to the offices of Wilson Sonsini Goodrich & Rosati by calling (650) 493-9300.

Q:

Why did I receive a one-page notice in the mail regarding the Internet availability of proxy materials
instead of a full set of proxy materials?

A:

In accordance with rules adopted by the Securities and Exchange Commission (the SEC), we have
elected to provide access to our proxy materials over the Internet. Accordingly, we began sending a Notice of Internet Availability of Proxy Materials (the Notice) to our shareholders of record and beneficial owners on or about
October 21, 2016.

All shareholders will be able to access the proxy materials on the website referred to
in the Notice, or to request a printed set of the proxy materials. Instructions on how to access the proxy materials over the Internet or to request a printed copy can be found in the Notice. In addition, shareholders may request the proxy
materials be sent by mail or email on an ongoing basis. Choosing to receive future proxy materials by email will save us the cost of printing and mailing documents to you, and will reduce the impact of our annual meetings on the environment.

Q:

What proposals will be voted on at the Annual Meeting?

A:

The proposals scheduled to be voted on at the Annual Meeting are:



The election of two Class I directors recommended by our Board of Directors to serve for a term of three years
or until their respective successors have been duly elected and qualified;



An advisory vote to approve the compensation paid to our named executive officers; and

The ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as our independent registered public
accounting firm for our fiscal year ending June 30, 2017.

Q:

What is the voting requirement to approve each of the proposals and how are votes counted?

A:

A plurality of the votes cast is required for the election of directors (Proposal One). You may vote
FOR or WITHHOLD on the nominee for election as director. The nominee for director receiving the highest number of affirmative votes will be elected as a director. Abstentions and broker non-votes will not affect the
outcome of the election. However, as set forth under Corporate Governance Majority Voting Policy in Uncontested Elections, we have a policy that if a director receives more Withhold votes than For votes
in an uncontested election such as this one, the director is expected to tender his or her resignation for consideration by the Nominating & Corporate Governance Committee and our Board of Directors.

The affirmative vote of a majority of the votes cast is required (1) to approve, on an advisory basis, the compensation paid to
our named executive officers (Proposal Two), and (2) to ratify the appointment of PricewaterhouseCoopers ABAS Ltd. as our independent registered public accounting firm for our fiscal year ending June 30, 2017 (Proposal Three). You may vote
FOR, AGAINST or ABSTAIN on these proposals. Abstentions have the same effect as votes against these proposals. However, broker non-votes are not deemed to be votes cast and, therefore, are not included
in the tabulation of voting results on these proposals.

All shares entitled to vote and represented by properly submitted
proxies received prior to the Annual Meeting (and not revoked) will be voted at the Annual Meeting in accordance with the instructions indicated by such proxy. If no instructions are indicated on such proxy, the shares represented by that proxy
will be voted as recommended by our Board of Directors.

Q:

How does the Board of Directors recommend that I vote?

A:

The Board of Directors recommends that you vote your shares:



FOR each of the two nominees recommended by our Board of Directors for election as Class I
directors (Proposal One);



FOR the approval, on an advisory basis, of the compensation paid to our named executive
officers (Proposal Two); and



FOR the ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as our
independent registered public accounting firm for our fiscal year ending June 30, 2017 (Proposal Three).

Q:

How many shares must be present or represented to conduct business at the Annual Meeting?

A:

The presence of the holders of at least one-third of the total shares entitled to vote at the Annual Meeting
is necessary to constitute a quorum at the Annual Meeting. Such shareholders are counted as present at the meeting if (1) they are present in person at the Annual Meeting or (2) have properly submitted a proxy.

Abstentions and broker non-votes are counted as present and entitled to vote and are, therefore, included for the
purposes of determining whether a quorum is present at the Annual Meeting.

A broker non-vote occurs when a
nominee holding shares for a beneficial owner has not received voting instructions from the beneficial owner, and the broker does not have, or declines to exercise, discretionary authority to vote those shares.

Q:

Who is entitled to vote at the Annual Meeting?

A:

You may vote your Fabrinet ordinary shares if our records show that you owned your shares at the close of
business on the Record Date. At the close of business on the Record Date, there were 36,778,321 ordinary shares outstanding and entitled to vote at the Annual Meeting. You may cast one vote for each ordinary share held by you as of the
Record Date on all matters presented.

Shares held in your name as the shareholder of record may be voted in person at the Annual
Meeting. Shares held beneficially in street name may be voted in person at the Annual Meeting only if you obtain a legal proxy from the broker, bank or nominee that holds your shares giving you the right to vote the
shares. Even if you plan to attend the Annual Meeting, we recommend you also submit your vote as described in the Notice and as described below, so your vote will be counted even if you later decide not to attend the meeting.

Q:

How can I vote my shares without attending the Annual Meeting?

A:

Whether you hold shares directly as the shareholder of record or beneficially in street name, you may direct
how your shares are voted without attending the Annual Meeting. If you are a shareholder of record, you may vote by submitting a proxy; please refer to the voting instructions in the Notice or below. If you hold shares beneficially in
street name, you may vote by submitting voting instructions to your broker, bank or nominee; please refer to the voting instructions provided to you by your broker, bank or nominee.

By InternetShareholders of record with Internet access may submit proxies until 11:59 p.m., Eastern time, on
December 14, 2016, by following the Vote by Internet instructions described in the Notice, or by following the instructions at www.proxyvote.com. Most Fabrinet shareholders who hold shares beneficially in street name may vote by
accessing the website specified in the voting instructions provided by their brokers, trustees or nominees. If you are a beneficial owner, please check the voting instructions provided by your broker, trustee or nominee for information
regarding Internet voting availability.

By telephoneDepending on how your shares are held, you may be able to
vote by telephone. If this option is available to you, you will have received information with the Notice or the voting instructions provided by your broker, bank or nominee explaining this procedure.

By mailShareholders of record may request a paper proxy card from Fabrinet and indicate their vote by completing,
signing and dating the card where indicated and by returning it in the prepaid envelope that will be included with the proxy card. Please follow the procedures outlined in the Notice to request a paper proxy card.

Q:

What is the difference between holding shares as a shareholder of record and as a beneficial owner?

A:

Shareholder of Record. If your shares are registered directly in your name with our transfer agent,
Computershare Trust Company, you are considered the shareholder of record with respect to those shares, and we have sent the Notice directly to you. As a shareholder of record, you have the right to grant your voting proxy directly
to us or to a third party, or to vote in person at the Annual Meeting.

Beneficial Owner. If your
shares are held in a brokerage account or by a bank or nominee, you are considered the beneficial owner of shares held in street name, and the Notice is being forwarded to you by your broker, bank or nominee (who is
considered the shareholder of record with respect to those shares). As the beneficial owner, you have the right to direct your broker, bank or nominee how to vote your shares. Your broker, bank or nominee has enclosed or provided voting
instructions for you to use in directing the broker, bank or nominee how to vote your shares. You are also invited to attend the Annual Meeting. However, because you are not the shareholder of record, you may not vote your shares in person
at the Annual Meeting unless you obtain a legal proxy from your broker, bank or nominee giving you the right to vote the shares at the Annual Meeting.

If you hold your shares through a broker and do not provide your broker with specific voting instructions, your broker will
have the discretion to vote your shares only on routine matters. As a result:



Your broker will not have the authority to exercise discretion to vote your shares with respect to the
election of directors and the advisory vote to approve the compensation paid to our named executive officers because the rules of The New York Stock Exchange (NYSE) treat those matters as non-routine; but

Your broker will have the authority to exercise discretion to vote your shares with respect to the
ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinets independent registered public accounting firm for Fabrinets fiscal year ending June 30, 2017, because NYSE rules treat that matter as routine.

Q:

What happens if additional matters are presented at the Annual Meeting?

A:

If any other matters are properly presented for consideration at the Annual Meeting, including, among other
things, consideration of a motion to adjourn the Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named as proxy holders will have discretion to vote on those
matters in accordance with their best judgment. We do not currently anticipate that any other matters will be raised at the Annual Meeting.

Q:

Can I change my vote?

A:

Subject to any rules your broker, bank or nominee may have, you may change your vote at any time before your
proxy is voted at the Annual Meeting.

If you are the shareholder of record, you may change your vote by
(1) granting a new proxy bearing a later date (which automatically revokes the earlier proxy) using any of the voting methods described above (and until the applicable deadline for each method), (2) providing a written notice of revocation to our
Corporate Secretary, c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, CA 94568 prior to your shares being voted, or (3) attending the Annual Meeting and voting in person. Attending the Annual Meeting will not cause your previously
granted proxy to be revoked unless you specifically request this.

If you are the beneficial owner of shares held in street
name, you may change your vote by (1) submitting new voting instructions to your broker, bank or nominee, or (2) attending the Annual Meeting and voting in person if you first have obtained a legal proxy from your broker, bank or nominee giving you
the right to vote your shares at the Annual Meeting.

Q:

What happens if I decide to attend the Annual Meeting but I have already voted or submitted a proxy card
covering my shares?

A:

Subject to any rules your broker, bank or nominee may have, you may attend the Annual Meeting and vote in
person even if you have already voted or submitted a proxy card. Any previous votes that were submitted by you will be superseded by the vote you cast at the Annual Meeting. Please be aware that attendance at the Annual Meeting will not,
by itself, revoke a proxy.

If a broker, bank or nominee beneficially holds your shares in street name and
you wish to attend the Annual Meeting and vote in person, you must obtain a legal proxy from the broker, bank or nominee holding your shares that gives you the right to vote the shares.

Q:

What should I do if I receive more than one set of voting materials?

A:

If you received more than one Notice, voting instruction card or set of proxy materials, your shares are
registered in more than one name or brokerage account. Please follow the instructions on each Notice or voting instruction card that you receive, to ensure that all of your shares are voted.

Q:

Is my vote confidential?

A:

Proxy instructions, ballots and voting tabulations that identify individual shareholders are handled in a
manner that protects your voting privacy. Your vote will not be disclosed either within Fabrinet or to third parties, except: (1) as necessary to meet applicable legal requirements, (2) to allow for the tabulation of votes and certification of
the vote, and (3) to facilitate a successful proxy solicitation. Occasionally, shareholders provide written comments on their proxy cards, which may be forwarded to Fabrinets management.

We will announce preliminary voting results at the Annual Meeting. We will also disclose voting results on a
Form 8-K filed with the SEC within four business days after the Annual Meeting, which will also be available in the InvestorsFinancialsSEC Filings section of our website at www.fabrinet.com.

Q:

Who will bear the cost of soliciting votes for the Annual Meeting?

A:

We will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials
and soliciting votes. We may reimburse brokerage firms, custodians, nominees, fiduciaries and other persons representing beneficial owners for their reasonable expenses in forwarding solicitation material to such beneficial owners. Our
directors, officers and employees also may solicit proxies in person or by other means of communication. Such directors, officers and employees will not be additionally compensated, but may be reimbursed for reasonable out-of-pocket expenses in
connection with such solicitation.

If you choose to access the proxy materials and/or vote over the
Internet, you are responsible for Internet access charges you may incur. If you choose to vote by telephone, you are responsible for telephone charges you may incur.

Q:

What is the deadline to propose actions for consideration at next years annual meeting of
shareholders or to nominate individuals to serve as directors?

A:

You may submit proposals, including recommendations of director candidates, for consideration at future
shareholder meetings.

For inclusion in Fabrinets proxy materialsShareholders may
present proper proposals for inclusion in our proxy statement and for consideration at our next annual meeting of shareholders by submitting their proposals in writing to our Corporate Secretary in a timely manner. In order to be included in
the proxy statement for our 2017 annual meeting of shareholders, shareholder proposals must be received by our Corporate Secretary no later than June 23, 2017, and must otherwise comply with the requirements of Rule 14a-8 of the Securities
Exchange Act of 1934, as amended (the Exchange Act).

To be brought before an annual meetingIn
addition, our memorandum and articles of association establish an advance notice procedure for shareholders who wish to present certain matters before an annual meeting of shareholders.

Nominations for the election of directors only can be made (1) by or at the direction of our Board of Directors, or (2) by a
shareholder who has delivered written notice to our Corporate Secretary within the Notice Period (as defined below) and who was a shareholder at the time of such notice and as of the record date for such meeting. The notice must contain
specified information about the nominees and about the shareholder proposing such nominations.

Our memorandum and articles
of association also provide that the only business that may be conducted at an annual meeting is business that is (1) properly brought before the meeting in accordance with our proxy materials with respect to such meeting, (2) properly brought
before the meeting by or at the direction of our Board of Directors, or (3) properly brought before the meeting by a shareholder who has delivered written notice to our Corporate Secretary, c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, CA
94568 within the Notice Period (as defined below) and who is a shareholder at the time of such notice and as of the record date for such meeting. The notice must contain specified information about the matters to be brought before such meeting
and about the shareholder proposing such matters.

The Notice Period is defined as that period not less than 45
days nor more than 75 days prior to the one year anniversary of the date on which we first mailed our proxy materials or a notice of availability of proxy materials (whichever is earlier) to shareholders in connection with the preceding years
annual meeting of shareholders. As a result, the Notice Period for the 2017 annual meeting of shareholders will start on August 7, 2017 and end on September 6, 2017.

If a shareholder who has notified us of his or her intention to present a
proposal at an annual meeting does not appear to present his or her proposal at such meeting, we need not present the proposal for vote at such meeting.

A copy of the full text of the provisions of our memorandum and articles of association discussed above may be obtained by
writing to our Corporate Secretary, c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, CA 94568, or by accessing Fabrinets filings on the SECs website at www.sec.gov.

All notices of proposals by shareholders, whether or not included in our proxy materials, should be sent to our Corporate
Secretary, c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, CA 94568.

Q:

How may I obtain a separate set of proxy materials or the 2016 Annual Report?

A:

If you share an address with another shareholder, each shareholder may not receive a separate copy of our
proxy materials and 2016 Annual Report. Upon written request we will promptly send a separate copy of our proxy materials and 2016 Annual Report, without charge, to any shareholder at a shared address where a single copy of the documents was
delivered. Shareholders may request additional copies of our proxy materials and 2016 Annual Report by contacting our investor relations at IR@fabrinet.com, or writing to Fabrinet, c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, CA
94568, Attention: Investor Relations. Shareholders who share an address and receive multiple copies of our proxy materials and 2016 Annual Report can also request to receive a single copy by following the instructions
above.

FISCAL YEAR END

This proxy statement provides information about the matters to be voted on at the 2016 Annual Meeting and additional
information about the Company and its executive officers and directors. Some of the information is provided as of the end of our 2014, 2015 or 2016 fiscal years, and some information is more recent. Our fiscal years end on the last Friday
of June of each calendar year; our 2014 fiscal year ended on June 27, 2014, our 2015 fiscal year ended on June 26, 2015, and our 2016 fiscal year ended on June 24, 2016.

Our amended and restated memorandum and articles of association provide that the number of our directors
will be fixed from time to time by our Board of Directors, but may not consist of more than 15 directors. Our Board of Directors presently consists of five directors who are divided into three classes with overlapping three-year terms as
follows:

Class I Directors(Term Expires in 2016)

Class II Directors(Term Expires in 2017)

Class III Directors(Term Expires in 2018)

Dr. Homa Bahrami

Thomas F. Kelly

David T. Mitchell

Rollance E. Olson

Dr. Frank H. Levinson

Upon expiration of the term of a class of directors, directors for that class will be elected
for three-year terms at the annual meeting of shareholders in the year in which that term expires. Any increase or decrease in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will
consist of one-third of the directors.

Nominees for Class I Director

Two candidates have been nominated for election as Class I directors at the Annual Meeting for a three-year term expiring in
2019. Upon the recommendation of the Nominating & Corporate Governance Committee, our Board of Directors has nominated Dr. Homa Bahrami and Rollance E. Olson for reelection as Class I directors. Biographical information for each of
the nominees is set forth below.

Each nominee has consented to being named in this proxy statement and to serving as a
director if elected, and we have no reason to believe any nominee will be unavailable to serve. In the event Dr. Bahrami or Mr. Olson is unable or declines to serve as a director at the time of the Annual Meeting, the proxies will be voted for
any nominee who may be proposed by the Nominating & Corporate Governance Committee and designated by the Board of Directors to fill the vacancy.

If you sign your proxy or voting instruction card or vote by telephone or over the Internet, but do not give instructions with
respect to the election of directors, your shares will be voted for the two persons recommended by our Board of Directors. If you wish to give specific instructions with respect to the election of directors, you may do so by indicating your
instructions on your proxy or voting instruction card, or when you vote by telephone or over the Internet. If you do not give voting instructions to your broker, your broker will not vote your shares on this matter.

Recommendation of the Board of Directors

The Board of Directors recommends a vote FOR the reelection of Dr. Homa Bahrami and Rollance E. Olson to our
Board of Directors.

The names of the members of our Board of Directors, their ages, their positions with Fabrinet and other biographical
information as of October 17, 2016, are set forth below. A discussion of the qualifications, attributes and skills of each of the directors and the director nominee that led our Board of Directors and the Nominating & Corporate
Governance Committee to conclude that he or she should serve as a director follows each of the biographies below. There are no family relationships among any of our directors or executive officers.

CommitteeMemberships

OtherPublicCo.Boards

Name

Age

DirectorSince

Position with Fabrinet

Independent

AC

CC

NCGC

David T. Mitchell

74

2000

Chief Executive Officer and Chairman of the Board

0

Dr. Homa Bahrami

61

2012

Director (Director Nominee)

ü

ü

Chair

0

Thomas F. Kelly

63

2010

Director

ü

Chair

ü

0

Dr. Frank H. Levinson

63

2001

Director

ü

ü

Chair

1

Rollance E. Olson

73

2004

Lead Independent Director (Director Nominee)

ü

ü

0

AC  Audit Committee

CC  Compensation Committee

NCGC  Nominating & Corporate Governance Committee

David T. (Tom) Mitchell is our founder and has served as our Chief Executive Officer
and Chairman of the Board of Directors since our inception in 2000. Mr. Mitchell also served as our President from 2000 to January 2011. In 1979, Mr. Mitchell co-founded Seagate Technology, a disk drive manufacturing company. Mr.
Mitchell served as the president of Seagate Technology from 1983 to 1991. From 1992 to 1995, Mr. Mitchell served as the chief operating officer of Conner Peripherals, a disk drive manufacturing company. From 1995 to 1998, Mr. Mitchell
served as the chief executive officer of JTS Corp., a mobile disk drive manufacturing company. During his tenure in the data storage industry, Mr. Mitchell established manufacturing operations in Singapore, Thailand, Malaysia, the PRC and
India. Mr. Mitchell was a member of the board of directors of GigOptix, Inc. from June 2012 through July 2013. Mr. Mitchell earned a bachelor of science degree in economics from Montana State University.

Among other skills and qualifications, Mr. Mitchell brings to our Board of Directors extensive knowledge and understanding of
Fabrinets business, operations and employees, having founded Fabrinet and served on our Board of Directors since our inception, as well as more than 30 years of experience in an array of executive management roles within the semiconductor and
optoelectronics industries.

Dr.Homa Bahrami has served on our Board of Directors since August
2012. Dr. Bahrami has been a Senior Lecturer at the Haas School of Business, University of California, Berkeley. She is also a Faculty Director of the Center for Executive Education and a Board Member of the Center for Teaching Excellence at
the Haas School of Business, where she has served on the faculty since 1986. Dr. Bahrami was a member of the board of directors of FEI Company (acquired by Thermo Fisher Scientific Inc. in 2016) from February 2012 through September 2016, where
she served on the audit and compensation committees, and a member of the board of directors of FormFactor, Inc. from 2004 through 2010. Dr. Bahrami earned a bachelor of arts degree with honors in sociology and social administration from Hull
University and a master of science degree in industrial administration and a doctor of philosophy degree in organizational behavior from Aston University in the United Kingdom.

Among other skills and qualifications, Dr. Bahrami brings to our Board of Directors experience in organizational design and
executive development for global enterprises.

Thomas F. Kelly has served on our Board of Directors since 2010. Mr.
Kelly served as chief executive officer and president of Moxie Software, a provider of enterprise social software, from January 2010 to January 2014. From June 2006 to June 2009, he was chairman of the board of MontaVista Software (acquired by
Cavium Networks, Inc. in 2009), a provider of Linux-based development software, where he was also chairman, president and chief executive officer from June 2006 to June 2008. From February 2008 to January 2009, he was president and chief
executive officer of Epicor Software, an enterprise resource planning software company, where he also served on the board of directors from 2000 to 2009. In 2004 and 2005, Mr. Kelly was with Trident Capital, a venture capital company. From
2001 to 2004, Mr. Kelly was chairman, president and chief executive officer of BlueStar Solutions (acquired by Affiliated Computer Services, Inc. in 2004), an enterprise resource planning software hosting company. From 1998 to 2001, Mr. Kelly
was chairman and chief executive officer of Blaze Software, Inc. (acquired by Brokat Infosystems AG in 2001). Prior to that, he served as chief financial officer or chief operating officer at several software and semiconductor companies,
including Cirrus Logic, Inc., Frame Technology, Cadence Design Systems, Valid Logic Corporation and Analog Design Tools. Earlier in his career he was with Arthur Anderson & Company. Mr. Kelly was a member of the board of directors of
FEI Company (acquired by Thermo Fisher Scientific Inc. in 2016) from September 2003 through September 2016, where he served as chairman of the audit committee. He is also on the Board of Regents of Santa Clara University. Mr. Kelly earned
a bachelor of science degree in economics from Santa Clara University.

Among other skills and qualifications,
Mr. Kelly brings to our Board of Directors audit and financial reporting expertise as well as managerial and operational experience gained from his service on the audit committees of multiple public companies and his roles at Cadence Design
Systems, Cirrus Logic, Frame Technology, Epicor Software, Trident Capital and various emerging growth technology companies.

Dr. Frank H. Levinson has served on our Board of Directors since 2001. Since 2006, Dr. Levinson has served as the
managing director of Small World Group, a group primarily involved in investing in and growing small companies. Dr. Levinson served as the chairman of the board of directors and chief technical officer of Finisar Corporation, a provider of
fiber optic components and network performance test and monitoring systems, from August 1999 to January 2006, and remained as a director of Finisar until August 2008. From 1988 to 1999, Dr. Levinson served as the chief executive officer of
Finisar. From January 1986 to February 1988, Dr. Levinson served as the optical department manager at Raynet, Inc., a fiber optic systems company and, from April 1985 to December 1985, as the chief optical scientist at Raychem
Corporation. From January 1984 to July 1984, Dr. Levinson was a member of the technical staff at Bellcore, a provider of services and products to the communications industry. From 1980 to 1983, Dr. Levinson was as a member of the
technical staff at AT&T Bell Laboratories. Since July 2014, Mr. Levinson has been a member of the board of directors of Interlink Electronics, Inc., where he currently serves as chairman of the compensation committee and a member of the
audit and nominating and governance committees. Dr. Levinson earned a bachelor of science degree in mathematics and physics from Butler University, and a masters degree in astronomy and a doctor of philosophy degree in astronomy from the
University of Virginia.

Among other skills and qualifications, Dr. Levinson brings to our Board of Directors executive
leadership and management experience in a global organization and semiconductor industry experience, having served as chairman of the board of directors, chief technical officer and chief executive officer of Finisar Corporation.

Rollance E. Olson has served on our Board of Directors since 2004, including as lead independent director since January
2011. From 1986 to 2011, Mr. Olson served as chief executive officer of Parts Depot Inc., a wholesale automotive replacement parts and supplies business in Virginia. From 1980 to 1985, Mr. Olson served as the president of Brake Systems,
Inc., and from 1973 to 1980, Mr. Olson served in various positions at Bendix Corporation, an automotive safety brake and control systems company, including as general manager of the Fram/Autolite division, general manager of the Bendix automotive
aftermarket division and corporate staff consultant. From 1968 to 1973, Mr. Olson served as a management consultant and project leader with Booz, Allen & Hamilton, a management and technology consultant firm. Mr. Olsons business
career started with Honeywell, Inc. in Minneapolis, Minnesota. Mr. Olson also served on the board of directors for several privately

owned retail and technology companies. He served as a board member (9 years) and chairman of the board of the largest automotive aftermarket trade association, and was a guest lecturer at
the Darden School of Business (University of Virginia). Mr. Olson earned a bachelor of arts degree from the University of Minnesota.

Among other skills and qualifications, Mr. Olson brings to our Board of Directors executive leadership and management
experience gained from his service as chief executive officer of Parts Depot Inc. for more than 25 years.

Compensation of Directors

Compensation for Fiscal 2016

The following table presents information regarding the compensation earned or paid in fiscal 2016 to individuals who were
members of our Board of Directors at any time during fiscal 2016, and who also were not our employees. We refer to those directors as non-employee directors. Mr. Mitchell does not receive additional compensation for his service as a
director.

Name

Fees Earned orPaid in Cash($)

Stock Awards($)(1)(2)

Total($)

Homa Bahrami

67,275

119,993

187,268

Thomas Kelly

79,000

119,993

198,993

Frank Levinson

73,000

119,993

192,993

Rollance Olson

174,000

119,993

293,993

Virapan Pulges(3)

32,750



32,750

(1)

Reflects the aggregate grant date fair value of the shares in accordance with FASB Accounting Standards
Codification Topic 718 (ASC 718). The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10-K for the year ended
June 24, 2016, filed with the SEC on August 17, 2016. These amounts do not correspond to the actual value that will be realized by the directors.

(2)

The following table presents the aggregate number of shares underlying unvested stock awards and outstanding
options held by each of our non-employee directors as of the end of fiscal 2016.

Name

Aggregate Number of SharesUnderlying Unvested StockAwards

Aggregate Number of SharesUnderlying OutstandingOptions

Dr. Bahrami

5,161



Mr. Kelly

5,161

30,000

Dr. Levinson

5,161



Mr. Olson

5,161



(3)

Mr. Pulgess term of office ended on December 17, 2015, the date of our 2015 annual meeting of
shareholders.

Standard Director Compensation Arrangements for Fiscal 2016

During fiscal 2016, non-employee directors received the following cash compensation for their service on our Board of
Directors:



an annual retainer of $49,000;



$45,000 per year for serving as Chairman of the Board of Directors (applicable only if the chairman is a
non-employee director);



$120,000 per year for serving as lead independent director of our Board of Directors (applicable only if the
chairman is an employee director);

$10,500 per year for each member of the Audit Committee (or $25,500 if such member is the chairperson);



$6,000 per year for each member of the Compensation Committee (or $13,500 if such member is the chairperson);
and



$5,000 per year for each member of the Nominating & Corporate Governance Committee (or $10,400 if such
member is the chairperson).

Non-employee directors also receive the following equity compensation for
their service on our Board of Directors:



upon joining our Board of Directors, an award of restricted share units pro-rated to reflect a value equal to:
$120,000, divided by the closing price of Fabrinets ordinary shares on the NYSE on the date of grant and multiplied by the number of days beginning with the date the director joins our Board of Directors and ending on the day immediately
preceding the one year anniversary of the prior years annual shareholder meeting, divided by 365 days; and



on the date of each annual shareholder meeting, an award of restricted share units valued at $120,000 based on
the closing price of Fabrinets ordinary shares on the NYSE on the date of each such annual shareholder meeting.

Restricted share units granted to directors generally will vest in full on January 1 following the next annual meeting of
shareholders after the date of grant, provided the director continues to serve through such date.

Standard Director Compensation
Arrangements for Fiscal 2017

Following the end of fiscal 2016, the cash compensation for serving as lead
independent director of our Board of Directors was reduced from $120,000 to $15,000 per year, effective August 15, 2016.

ADVISORY VOTE TO APPROVE COMPENSATION PAID TO NAMED EXECUTIVE OFFICERS

General

In accordance with SEC rules, we are providing our shareholders with the opportunity to vote to approve, on an advisory or
non-binding basis, the compensation of our named executive officers (or Named Officers) as disclosed in this proxy statement in accordance with rules of the SEC. This proposal, commonly known as a say-on-pay proposal, gives
our shareholders the opportunity to express their views on our Named Officers compensation as a whole. This vote is not intended to address any specific item of compensation or any specific Named Officer, but rather the overall compensation of
all of our Named Officers and the compensation philosophy, policies and practices described in this proxy statement. We currently hold our say-on pay vote every year.

While this advisory vote to approve executive compensation is non-binding, it will provide information to us regarding
investor sentiment about our executive compensation philosophy, policies and practices, which the Compensation Committee will be able to consider when making future executive compensation decisions. Our Board of Directors and the Compensation
Committee value the opinions of shareholders and, to the extent there is any significant vote against the Named Officer compensation as disclosed in this proxy statement, will endeavor to communicate with shareholders to better understand the
concerns that influenced the vote, consider those shareholders concerns and evaluate whether any actions are necessary to address those concerns.

We urge shareholders to read the Executive Compensation section of this proxy statement, and in particular the
information discussed under the heading Executive CompensationCompensation Discussion and Analysis, which describes in more detail how our executive compensation policies and procedures operate and are designed to achieve our
compensation objectives. We believe that our executive compensation program is working to ensure managements interests are aligned with our shareholders interests to support long-term value creation. Accordingly, pursuant to Section 14A
of the Exchange Act, you are being asked to vote FOR the following resolution at the Annual Meeting:

RESOLVED, that Fabrinets shareholders approve, on an advisory basis, the compensation of Fabrinets named
executive officers, as disclosed in Fabrinets Proxy Statement for the 2016 Annual Meeting of Shareholders pursuant to the executive compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion
and Analysis, the compensation tables, and related narrative disclosures.

Recommendation of the Board of Directors

The Board of Directors recommends a vote FOR the approval, on an advisory basis, of the
compensation paid to our Named Officers.

The Audit Committee has appointed PricewaterhouseCoopers ABAS Ltd. (PwC) as our independent registered public
accounting firm for our fiscal year ending June 30, 2017. Although ratification by shareholders is not required by any applicable legal requirements, our Board of Directors has determined it is desirable to request ratification of this selection by
our shareholders. Notwithstanding its selection, the Audit Committee, in its discretion, may appoint a new independent registered public accounting firm at any time during the year if the Audit Committee believes that such a change would be in the
best interests of Fabrinet and its shareholders. If our shareholders do not ratify the appointment of PwC, the Audit Committee may reconsider its selection.

A representative of PwC is expected to be present at the meeting, will have the opportunity to make a statement if he or she
desires to do so, and is expected to be available to respond to appropriate questions.

Recommendation of the Board of
Directors

The Board of Directors recommends a vote FOR the ratification of the appointment of
PricewaterhouseCoopers ABAS Ltd. as Fabrinets independent registered public accounting firm for the fiscal year ending June 30, 2017.

Accounting Fees

The following table presents fees paid or accrued by Fabrinet for audit and other services
rendered by PwC for fiscal 2016 and fiscal 2015.

Fiscal 2016

Fiscal 2015

Audit Fees(1)

$

817,209

$

570,356

Audit-Related Fees





Tax Fees





All Other Fees





Total

$

817,209

$

570,356

(1)

Audit Fees consist of fees for professional services provided in connection with the audit of our annual
consolidated financial statements, the review of our quarterly consolidated financial statements, and audit services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings
or engagements for those fiscal years, such as statutory audits, as well as out of pocket expenses.

Pre-Approval of Audit and Non-Audit Services

Pursuant to its charter, the Audit Committee is required to (1) review and approve,
in advance, the scope and plans for all audits and audit fees and (2) approve, in advance, all non-audit services to be performed by our independent auditors.

All services and fees of PwC were pre-approved by the Audit Committee.

The Audit Committee assists our Board of Directors in fulfilling its responsibilities for oversight of the integrity of our
financial statements, our internal accounting and financial controls, our compliance with legal and regulatory requirements, the organization and performance of our internal audit function and the qualifications, independence and performance of our
independent registered public accounting firm.

Our management is responsible for establishing and maintaining internal
controls and preparing our consolidated financial statements. The independent registered public accounting firm is responsible for auditing the financial statements. It is the responsibility of the Audit Committee to oversee these
activities.

The Audit Committee has:



Reviewed and discussed the audited financial statements with management and with PricewaterhouseCoopers ABAS
Ltd., our independent registered public accounting firm;



Discussed with PricewaterhouseCoopers ABAS Ltd. the matters required to be discussed under the rules adopted
by the Public Company Accounting Oversight Board (the PCAOB); and



Received the written disclosures and the letter from PricewaterhouseCoopers ABAS Ltd. required by applicable
requirements of the PCAOB regarding PricewaterhouseCoopers ABAS Ltd.s communications with the Audit Committee concerning independence and has discussed with PricewaterhouseCoopers ABAS Ltd. its independence.

Based upon these discussions and review, the Audit Committee recommended to our Board of Directors that the audited financial
statements be included in our Annual Report on Form 10-K for the fiscal year ended June 24, 2016, for filing with the United States Securities and Exchange Commission.

Respectfully submitted by the members of the Audit Committee of the Board of Directors.

We have adopted Corporate Governance Guidelines that establish the corporate governance policies our Board of Directors intends
to follow in overseeing our business in accordance with its fiduciary duties. The Corporate Governance Guidelines are available in the InvestorsGovernance section of our website at www.fabrinet.com.

Code of Business Conduct

We are committed to maintaining the highest standards of ethical conduct, with business practices and principles of behavior
that support this commitment. Accordingly, our Board of Directors has adopted a Code of Business Conduct, which is applicable to all of our directors, officers (including our principal executive officer and senior financial and accounting officers)
and employees. The Code of Business Conduct is available in the InvestorsGovernance section of our website at www.fabrinet.com. We will disclose on our website any amendments to the Code of Business Conduct, as well as any waivers,
required to be disclosed by SEC or NYSE rules.

Majority Voting Policy in Uncontested Elections

Our Board of Directors endorses the principle of using a majority voting standard for uncontested elections of directors.
Accordingly, in an election of directors such as this one, a nominee who receives more Withhold votes than For votes is expected to promptly tender his or her resignation as a director. The Nominating & Corporate
Governance Committee will then consider each tendered director resignation and recommend to our Board of Directors whether to accept or reject it. After considering the recommendation of the Nominating & Corporate Governance Committee and any
other information the Board deems appropriate, our Board of Directors will act to accept or reject each tendered director resignation. Any director who tenders a resignation under the majority voting policy may not participate in the Nominating
& Corporate Governance Committees recommendation or the action of our Board of Directors regarding whether to accept or reject such tender of resignation.

Board Leadership Structure

Mr. Mitchell currently serves as chairman of our Board of Directors and as our chief executive officer. Our Corporate
Governance Guidelines provide that our Board of Directors will fill the chairman and chief executive officer (CEO) positions based upon what it believes is in our best interests at any point in time. Currently, our Board of Directors does not
require separation of the chairman and CEO positions. Our Board of Directors believes that as CEO, Mr. Mitchell is in the best position to direct the focus and attention of our Board of Directors to the areas most relevant for us and our
shareholders, as Mr. Mitchell is the most familiar with our business, industry and strategic priorities. By combining the role of chairman and CEO, Mr. Mitchell is able to provide strong and valuable leadership for us both internally and externally.

In addition, our Corporate Governance Guidelines provide that if the CEO also is the chairman, our Board of Directors
shall select, at its first regular meeting following each annual shareholder meeting, a lead independent director. Rollance Olson has served as our lead independent director since January 2011. The lead independent directors duties
include coordinating the activities of the independent and other non-employee directors, coordinating the agenda for and moderating sessions of the independent and other non-employee directors, and facilitating communications among our entire Board
of Directors.

Our independent directors meet in executive session at each regularly scheduled meeting of our Board of
Directors, and at such other times as necessary or appropriate as determined by the independent directors. Our lead independent director presides at such executive sessions of our Board of Directors.

Our Board of Directors is responsible for the oversight of our enterprise risk management. Together with its committees, our
Board of Directors ensures that any material risks relevant to us or our business are appropriately considered and addressed. Our management team is responsible for day-to-day risk management. Managements responsibilities include identifying,
evaluating and addressing potential risks that may exist at the enterprise, strategic, financial and operating levels and the development of processes for mitigating these risks, and our Board of Directors, together with its committees, oversees
management in its execution of these responsibilities. At periodic meetings of our Board of Directors and board committees, and in other meetings and discussions, our management reports to and seeks guidance from our Board of Directors and its
committees, as applicable, with respect to matters that could affect our business. In addition, our legal counsel provides reports of legal risks to the Audit Committee and to our Board of Directors. Similarly, our chief financial officer
provides reports to the Audit Committee concerning financial, tax and audit related risks. In addition, the Audit Committee receives periodic reports from management on our compliance programs and efforts, investment policy and practices.

Our Board of Directors reviews the strategic, financial and operational risks inherent in our business through its
consideration of the various matters presented to our Board of Directors or its committees by management for review or approval. Furthermore, each board committee regularly reviews and evaluates various aspects of enterprise risk as part of its
specific functions and responsibilities delegated by our Board of Directors. The Audit Committee considers risk in connection with its oversight of our financial review and reporting processes and regulatory and corporate compliance
matters. In addition, the Audit Committee is responsible for the oversight and review of certain risk management policies, including our insurance, investment and business continuity policies. The Compensation Committee considers risk in
connection with its oversight of the design and administration of our compensation policies, plans and programs. The Nominating & Corporate Governance Committee considers risk in connection with its oversight of our governance structure,
policies and processes, including conflicts of interest (other than related party transactions reviewed by the Audit Committee).

We believe that our Board of Directors role is consistent with our leadership structure, with our CEO and management
primarily responsible for enterprise risk management, and with our Board of Directors and its committees providing oversight of these efforts.

Contacting our Board of Directors

Shareholders and other interested parties may communicate directly with our lead independent director by sending an email to
leadindependentdirector@fabrinet.com. Communications received at this email address are automatically routed directly to our lead independent director. Shareholders and other interested parties who wish to communicate with our Board of
Directors may do so by sending an email to board@fabrinet.com or a written communication addressed to Fabrinet, c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, California 94568, Attention: Board of Directors. Our legal counsel reviews
all incoming communications from shareholders and other interested parties (except for communications sent directly to the lead independent director, mass mailings, product complaints or inquiries, job inquiries, business solicitations and patently
offensive or otherwise inappropriate material) and, as appropriate, routes such communications to the appropriate member(s) of our Board of Directors, or if none is specified, to the Chairman of the Board.

Attendance at Annual Meetings of Shareholders by our Board of Directors

Although we do not have a formal policy regarding attendance by members of our Board of Directors at our annual meeting of
shareholders, we encourage, but do not require, directors to attend. All of our directors attended our 2015 annual meeting of shareholders.

Our ordinary shares are listed on the NYSE. Pursuant to the NYSE listing standards, independent directors must comprise a
majority of our Board of Directors, and each member of our Audit, Compensation, and Nominating & Corporate Governance Committees must be independent. A director will only qualify as an independent director if, in the opinion of
our Board of Directors, that director does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

Audit Committee members also must satisfy the independence criteria set forth in Rule 10A-3 under the Exchange
Act. In order to be considered independent for purposes of Rule 10A-3, a member of the Audit Committee may not, other than in his or her capacity as a member of the Audit Committee, our Board of Directors, or any other Board committee:
(1) accept, directly or indirectly, any consulting, advisory, or other compensatory fee from us or any of our subsidiaries; or (2) be an affiliated person of us or any of our subsidiaries.

Compensation Committee members must satisfy additional independence criteria set forth under the NYSE listing standards. In
order for a member of the Compensation Committee to be considered independent, our Board of Directors must consider all factors specifically relevant to determining whether a director has a relationship to us that is material to that directors
ability to be independent from management in connection with the duties of a Compensation Committee member, including, but not limited to: (1) the source of compensation of such director, including any consulting, advisory, or other
compensatory fee paid by us to such director; and (2) whether such director is affiliated with us, any of or subsidiaries, or an affiliate of any of our subsidiaries.

Our Board of Directors has reviewed the independence of each director and determined that Dr. Bahrami, Mr. Kelly,
Dr. Levinson and Mr. Olson, representing four of our five directors, do not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors
is independent as that term is defined under the applicable rules and regulations of the SEC and the NYSE listing standards. In making these determinations, our Board of Directors considered the current and prior relationships that each
non-employee director has with us and all other facts and circumstances our Board of Directors deemed relevant.

Board
Meetings and Committees

During fiscal 2016, our Board of Directors held twelve meetings and also took certain actions
by written consent. Each of our directors attended at least 75% of the meetings of our Board of Directors and the committees on which he or she served during fiscal 2016. Our Board of Directors has established an Audit Committee, a
Compensation Committee and a Nominating & Corporate Governance Committee, each of which has the composition and responsibilities described below.

Audit Committee

The Audit Committee currently consists of Mr. Kelly (chairman), Dr. Bahrami and Dr. Levinson, each of whom is independent under
the NYSE listing standards and the rules and regulations of the SEC. Our Board of Directors has determined that Mr. Kelly qualifies as an audit committee financial expert under the rules and regulations of the SEC and that each
member of the Audit Committee meets the financial literacy requirements of the NYSE listing standards. The Audit Committee held four meetings during fiscal 2016.

Among other responsibilities, the Audit Committee (1) oversees our accounting and financial reporting processes and the audit
of our financial statements, (2) assists our Board of Directors in overseeing the integrity of our financial statements (including, without limitation, internal control over financial reporting), (3) oversees our compliance with ethics policies and
legal and regulatory requirements, (4) oversees the performance of our independent auditors, (5) prepares the disclosure required by applicable law and SEC rules, and (6) provides to

our Board of Directors such information and materials as it may deem necessary to make our Board of Directors aware of significant financial matters that require the attention of our Board of
Directors. The Audit Committee acts in accordance with a written charter adopted by our Board of Directors, which is available in the InvestorsGovernance section of our website at www.fabrinet.com.

The Audit Committee report is included in this proxy statement on page 17.

Compensation Committee

The Compensation Committee currently consists of Dr. Levinson (chairman) and Mr. Kelly, each of whom is independent under the
NYSE listing standards and the rules and regulations of the SEC. In addition, our Board of Directors has determined that Dr. Levinson and Mr. Kelly meet the requirements of the non-employee director definition of Rule 16b-3 promulgated under
the Exchange Act and the outside director definition of Section 162(m) of the Internal Revenue Code, as amended. The Compensation Committee held four meetings during fiscal 2016 and also took certain actions by written consent.

Among other responsibilities, the Compensation Committee (1) develops, reviews and approves our overall compensation policies
and goals, including policies and forms of compensation provided to our directors and executive officers, (2) oversees the administration of our equity compensation and employee benefit plans and programs, and (3) produces an annual report on
executive officer compensation for inclusion in our annual proxy statement. The Compensation Committee acts in accordance with a written charter adopted by our Board of Directors, which is available in the InvestorsGovernance
section of our website at www.fabrinet.com.

The Compensation Committee report is included in this proxy statement on page
36.

Nominating & Corporate Governance Committee

The Nominating & Corporate Governance Committee currently consists of Dr. Bahrami (chairwoman) and Mr. Olson, each of whom
is independent under the NYSE listing standards and the rules and regulations of the SEC. The Nominating & Corporate Governance Committee held four meetings during fiscal 2016 and also took certain actions by written consent.

Among other responsibilities, the Nominating & Corporate Governance Committee (1) assists our Board of Directors in
identifying prospective director nominees, (2) recommends candidates for election to our Board of Directors at each annual meeting of shareholders, (3) reviews and recommends updates to our corporate governance principles, as appropriate, (4)
reviews and recommends directors to serve on each board committee, (5) oversees the annual evaluation of our Board of Directors and its committees, and (6) monitors and reviews matters related to succession planning for our executives
officers. The Nominating & Corporate Governance Committee acts in accordance with a written charter adopted by our Board of Directors, which is available in the InvestorsGovernance section of our website at
www.fabrinet.com.

The Nominating & Corporate Governance Committee will consider recommendations of candidates for
election to our Board of Directors submitted by shareholders of Fabrinet. For more information, see Process for Recommending Candidates for Election to the Board of Directors below.

Share Ownership Guidelines

We have adopted share ownership guidelines for our directors and executive officers. For information regarding such guidelines,
see the section of this proxy statement entitled Executive CompensationCompensation Discussion and AnalysisShare Ownership Guidelines.

During fiscal 2016, Dr. Levinson, Mr. Kelly and Mr. Pulges served as members of the Compensation Committee. None of the members
of the Compensation Committee is or has in the past served as an officer or employee of Fabrinet. None of our executive officers serves as a member of the Board of Directors or compensation committee of any entity that has one or more executive
officers serving as a member of our Board of Directors or Compensation Committee.

Process for Recommending Candidates for
Election to the Board of Directors

The Nominating & Corporate Governance Committee is responsible for, among other
things, determining the criteria for membership to our Board of Directors, and recommending candidates for election to our Board of Directors. The Nominating & Corporate Governance Committee will consider recommendations from shareholders
for candidates to serve on our Board of Directors. There are no differences in the manner by which the Nominating & Corporate Governance Committee evaluates nominees for director based on whether the nominee is recommended by a shareholder
or our Board of Directors.

Shareholder Recommendations and Nominees

Shareholder recommendations for candidates to our Board of Directors must be directed in writing to our Corporate Secretary,
c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, California 94568, and must include (1) the candidates name, age, business address and residence address, (2) the candidates principal occupation or employment, (3) the class and
number of shares that are held of record or beneficially owned by the candidate and any derivative positions held or beneficially held by the candidate, (4) whether and the extent to which any hedging or other transaction or series of transactions
has been entered into by or on behalf of the candidate with respect to any of our securities, and a description of any other agreement, arrangement or understanding (including any short position or any borrowing or lending of our shares), the effect
or intent of which is to mitigate loss to, or to manage the risk or benefit of share price changes for, or to increase or decrease the voting power of the candidate, (5) a description of all arrangements or understandings between the nominating
shareholder and each candidate and any other person or persons pursuant to which the nominations are to be made by the nominating shareholder, (6) a written statement executed by the candidate acknowledging that as a director, the candidate will owe
a fiduciary duty under Cayman Islands law with respect to Fabrinet and its shareholders, and (7) any other information relating to the candidate that would be required to be disclosed about such candidate if proxies were being solicited for the
election of the candidate as a director, or that is otherwise required, in each case pursuant to Regulation 14A under the Exchange Act (including, without limitation, the candidates written consent to being named in the proxy statement, if
any, as a nominee and to serving as a director if elected).

Shareholder recommendations for candidates to our Board of
Directors must also contain specified information about the shareholder proposing such nomination. For more information, please refer to our memorandum and articles of association, which may be obtained by writing to our Corporate Secretary,
c/o Fabrinet USA, Inc., 3736 Fallon Road, #428, Dublin, California 94568, or by accessing Fabrinets filings on the SECs website at www.sec.gov.

Director Qualifications

The Nominating & Corporate Governance Committee will evaluate and recommend candidates for membership on our Board of
Directors consistent with any criteria established by the committee. The consideration of any candidate for director will be based on the committees assessment of the individuals background, experience, skills and abilities, and if
such characteristics qualify the individual to fulfill the needs of our Board of Directors at that time. While the Nominating & Corporate Governance Committee has not established specific minimum qualifications or a formal diversity policy
for director candidates, the committee

believes that candidates and nominees should reflect a Board of Directors that is predominately independent and that is comprised of directors who (1) are of high integrity, (2) have broad,
business-related knowledge and experience, (3) have qualifications that will increase overall board effectiveness, (4) have diverse backgrounds and perspectives, and (5) meet other requirements as may be required by applicable rules, such as
financial literacy or financial expertise with respect to Audit Committee members.

Identification and Evaluation of Director
Nominees

The Nominating & Corporate Governance Committee uses a variety of methods for identifying and
evaluating director nominees. The committee assesses the appropriate size and composition of our Board of Directors, the needs of our Board of Directors and board committees and the qualifications of candidates in light of these
needs. Candidates may come to the attention of the Nominating & Corporate Governance Committee through shareholders, management, current members of our Board of Directors or search firms. The evaluation of these candidates may be based
solely upon information provided to the committee or may also include discussions with persons familiar with the candidate, an interview of the candidate or other actions the committee deems appropriate, including the use of third parties to review
candidates.

The names of our executive officers, their ages, their positions with us and other biographical information as of October 17,
2016, are set forth below. There are no family relationships among any of our directors or executive officers.

Dr.Harpal
Gill has served as president of Fabrinet USA, Inc. since January 2011, and as chief operating officer of Fabrinet USA, Inc. since March 2009. Dr. Gill also has served as executive vice president, operations of Fabrinet Co., Ltd. since July
2007 and as senior vice president, operations of Fabrinet USA, Inc. from May 2005 to March 2009. From July 2003 to January 2005, Dr. Gill served as vice president of engineering and then senior vice president of engineering for Maxtor
Corporation, a disk drive manufacturer. From January 1999 to July 2003, Dr. Gill served as the vice president of engineering for Read Rite Corporation, a supplier of magnetic recording heads for data storage devices. From June 1996 to
October 1998, Dr. Gill served as the managing director of JTS Corp., a disk drive manufacturer. Dr. Gill also has held senior management positions with Seagate Technology and Stanton Automation. Dr. Gill earned a bachelor of science degree
in mechanical engineering from Brunel University and a doctor of philosophy degree in engineering from the University of Bradford.

Toh-Seng Ng has served as executive vice president and chief financial officer of Fabrinet USA, Inc. since March
2012. Previously, he was senior vice president of finance and managing director of Casix, Inc., our subsidiary in the Peoples Republic of China, from March 2010 to March 2012, and senior vice president and operations controller of
Fabrinet from January 2007 to March 2010. Mr. Ng joined us with nearly 28 years of international financial management experience in the semiconductor and data storage industries. Prior to joining us, Mr. Ng managed financial operations at
Magnecomp Precision Plc. in Thailand, Hitachi Global Storage Technologies in San Jose, and Read-Rite Corporation in a series of positions, culminating in his role as corporate controller and vice president of finance. Mr. Ng earned a bachelor
of science degree in accountancy from the University of Singapore, and a master of business administration degree in international management from Golden Gate University.

Dr. Hong Q. Hou has served as executive vice president and chief technical officer of Fabrinet USA, Inc. since January
2016. Prior to joining us, Dr. Hou served as the chief operating officer of AXT, Inc., a manufacturer of semiconductor substrates, from June 2015 to January 2016, and as a venture partner at ARCH Venture Partners from January 2015 to June
2015. Prior to that, Dr. Hou served as president, chief executive officer and a member of the board of directors of EMCORE Corporation, a provider of compound semiconductor-based components and subsystems, from 2008 to January 2015. Dr. Hou
holds eight U.S. patents and has published more than 200 technical articles. Dr. Hou holds a doctor of philosophy degree in electrical engineering from the University of California at San Diego, and he has completed executive management courses
at the Stanford Graduate School of Business.

This section contains a discussion of the material elements of compensation awarded to, earned by or paid to our principal
executive officer, principal financial officer, and the other individuals included in the Summary Compensation Table beginning on page 37. We refer to these individuals as our Named Officers in this proxy statement. For
fiscal 2016, our Named Officers were:



David T. Mitchell, Chief Executive Officer (CEO) and Chairman of the Board of Directors;

At our 2015 annual meeting of shareholders,
approximately 28% of the votes cast in the say-on-pay advisory vote were voted in favor of our executive compensation as disclosed in our 2015 proxy statement. This represented a significant decline compared to the results of our 2014
say-on-pay advisory vote, when approximately 74% of the votes cast were voted in favor of our executive compensation as disclosed in our 2014 proxy statement. In response to the results of our 2015 say-on-pay vote, the Compensation Committee
contacted shareholders to understand better their priorities and concerns with respect to our executive pay practices, examined the reports and analyses issued by the principal proxy advisory services, and engaged a proxy advisory firm to advise the
Compensation Committee.

During the Summer of 2016, the Compensation Committee solicited the views of institutional
investors representing approximately 49% of our outstanding shares and had discussions with and received feedback on our executive compensation practices from investors representing approximately 20% of our outstanding shares, including four of our
ten (and nine of our 20) largest shareholders. Dr. Levinson, the Chairman of the Compensation Committee, attended all of these discussions. He was joined by Mr. Kelly, the other member of the Compensation Committee, and Mr. Olson, our lead
independent director, for many of the discussions. The feedback received was presented to the Compensation Committee and our Board of Directors. In addition, we conferred with representatives of Institutional Shareholder Services in the
Spring of 2016 to discuss our compensation practices. The principal feedback we received from shareholders and the response of the Compensation Committee is noted in the chart below.

Shareholder Concern or Request

Compensation Committee Response

Fiscal 2015 executive compensation appeared excessive and should be based upon and evaluated against an appropriate peer
group.

We believe our executive management team is the very best in the electronics manufacturing space, as evidenced by our
consistent growth and profitability over the last four years, and we compensate the team accordingly.

We believe the compensation paid to our entire executive management team (four persons), when viewed in total, is less
than the total compensation paid to the executive management teams of comparable companies.

We believe it would be very difficult to replace our executives, especially since our headquarters and manufacturing
facilities are located in Thailand. Because of this, we have designed executive compensation packages that we believe are necessary and in the best interest of Fabrinet to retain our executive management team.

Equity awards should include performance-based metrics that span multiple years.

While we granted equity awards following fiscal 2015 and fiscal 2016 that were based, in part, on fiscal 2015 and fiscal
2016 performance, respectively, we introduced performance share units, or PSUs, in fiscal 2017. The PSUs will be earned, if at all, over a 2-year performance period based on company achievement of challenging revenue and gross margin
targets. See Recent Fiscal 2017 Compensation Decisions below for more information.

Incentive compensation should be subject to a clawback.

In October 2016, we adopted a clawback policy applicable to our executive officers. See Compensation Recovery
Policy below for more information.

Recent Fiscal 2017 Compensation Decisions

In light of the results of our 2015 say-on-pay vote and the subsequent feedback we received from shareholders, the Compensation
Committee modified some elements of our executive compensation program for fiscal 2017, primarily to enhance the link between executive pay and longer-term company performance, as summarized below. Because the Compensation Committee had approved
fiscal 2016 executive compensation prior to our 2015 annual shareholder meeting, the Compensation Committee was unable to consider such shareholder feedback in setting fiscal 2016 executive compensation. Accordingly, the compensation changes we
made in response to our 2015 say-on-pay vote will not show up in the Summary Compensation Table until we report fiscal 2017 compensation in our 2017 proxy statement.

As noted above, the biggest change in our fiscal 2017 compensation program is the introduction
of PSUs. The number of PSUs earned and eligible to vest will be determined after a two-year performance period, based 50% on achievement of cumulative fiscal 2017 and fiscal 2018 revenue targets and 50% on achievement of cumulative fiscal 2017 and
fiscal 2018 gross margin targets. Any earned PSUs will vest in full on the date the Compensation Committee certifies achievement of the performance criteria.

We also amended agreements with our CEO, COO and CFO to limit the vesting acceleration provisions in those agreements to
equity-based awards granted prior to August 2016 (except for restricted share units granted in August 2016 that were based on fiscal 2016 performance). The PSUs we granted in fiscal 2017 are not subject to accelerated vesting under the
agreements with our CEO, COO and CFO.

Positive Compensation Practices

We monitor trends and developments in compensation practices to enhance the effectiveness of our compensation philosophy and
have adopted the following practices:



our executive officers cash and equity incentive compensation is subject to a clawback;



we employ each of our executive officers at will;



we have adopted a practice of granting long-term equity to our executive officers that is based, in part, on
Fabrinet achieving financial performance goals, including the introduction of PSUs granted in fiscal 2017 that will be earned over a two-year performance period;

our equity incentive plan prohibits us from instituting any program to reprice or exchange equity awards for
awards with a lower exercise price without shareholder approval;



our equity incentive plan prohibits us from recycling shares, which means that any shares subject
to a grant are counted against the share limit in the plan and may not subsequently be re-granted, even if the shares are forfeited, expired or exchanged;



our equity incentive plan provides that all awards are subject to the award recipients continued
employment or other service with the Company and vest over a four-year period, unless otherwise set forth in the award agreement; and



we hold an annual shareholder advisory vote on executive compensation.

Our executive compensation programs are intended to achieve three fundamental objectives: (1) attract, retain and motivate
qualified executives; (2) hold executives accountable for performance; and (3) align executives interests with the interests of our shareholders. In structuring and designing our executive compensation programs, we are guided by the
following basic philosophies:



Competition. We should provide competitive compensation opportunities with respect to our industry so
we can attract, retain and motivate qualified executives.



Alignment with Shareholder Interests. A substantial portion of compensation should be contingent on our
performance for our shareholders, to align the interests of executives with the interests of our shareholders and to hold the executives accountable for our performance.

As described in more detail below, the material elements of our executive compensation programs for our Named Officers include
a base salary, short-term cash incentive awards and long-term equity incentive awards. In addition, our Named Officers may participate in our 401(k) plan and employee benefit programs on substantially the same terms as our other employees. Our Named
Officers also are entitled to certain perquisites and personal benefits and, in some cases, are entitled to severance benefits upon certain terminations of their employment with us.

We believe each element of our executive compensation program helps us to achieve one or more of our compensation
objectives. Taken together, the compensation elements are intended to provide a total compensation package for each Named Officer that is competitive. The table below lists each material element of our executive compensation program and the
compensation objective or objectives it is designed to achieve.

Compensation Element

Compensation Objectives Designed to be
Achieved

Base salary

 Attract, retain and motivate qualified executives.

Short-term cash incentives

 Align executives interests with those of shareholders;

 Hold executives accountable for our performance; and

 Attract, retain and motivate qualified executives.

Long-term equity incentives

 Align executives interests with those of shareholders;

 Hold executives accountable for our performance; and

 Attract, retain and motivate qualified executives.

Perquisites and personal benefits

 Attract, retain and motivate qualified executives.

Severance and other benefits upon termination of employment

 Attract, retain and motivate qualified executives.

Role and Authority of the Compensation Committee

The Compensation Committee currently consists of Dr. Levinson (chairman) and Mr. Kelly, each of whom is independent
within the meaning of NYSE rules. In addition, our Board of Directors has determined that Dr. Levinson and Mr. Kelly meet the requirements of the non-employee director definition of Rule 16b-3 promulgated under the Exchange Act and the
outside director definition of Section 162(m) of the Internal Revenue Code, as amended. No Compensation Committee member is a former or current officer or employee of Fabrinet or any of its subsidiaries. The Compensation Committee meets at
least quarterly, and members of the Compensation Committee serve at the discretion of our Board of Directors.

The Compensation Committee is responsible for overseeing our compensation
policies and goals and administering our equity compensation plans and executive incentive plan, including approving target and actual bonuses under our executive incentive plan. Additionally, the Compensation Committee is responsible for reviewing
and approving the compensation of our chief executive officer and other Named Officers. The Compensation Committees role is detailed in its charter, which is available in the InvestorsGovernance section of our website at
www.fabrinet.com.

Pursuant to its charter, the Compensation Committee may delegate its authority to grant awards under
the Companys incentive compensation or other equity-based plans, except with respect to awards to executive officers and directors. The Compensation Committee has delegated limited, non-exclusive authority to a committee consisting of our
chief executive officer and chief financial officer (the Equity Award Committee) to grant equity awards under our 2010 Performance Incentive Plan with respect to consultants, new hires and promotions for employees below the level of vice
president (and with respect to new hires, for employees who are not expected to shortly thereafter become a vice president or above). In any fiscal year, the Equity Award Committee may grant, in the aggregate, share options and share appreciation
rights, restricted share units, restricted shares or other full-value awards covering no more than the number of shares that have been budgeted and approved by the Compensation Committee for such fiscal year. The Equity Award Committee did not take
action during fiscal 2016, and the Compensation Committee did not approve a budget of equity awards for the Equity Award Committee for fiscal 2016. The Compensation Committee has not delegated any of its authority with respect to any component
of the compensation of our Named Officers.

Role of the Independent Compensation Consultant

The Compensation Committee has the authority, in its sole discretion, to engage the services of outside consultants to assist
it in making decisions regarding the establishment of our compensation programs and philosophy. The Compensation Committee also may obtain advice and assistance from internal or external legal, accounting or other advisors. For fiscal 2016, the
Compensation Committee retained Compensia, Inc., a national compensation consulting firm, to provide independent compensation consulting services. If requested by the Compensation Committee, a representative of Compensia attends meetings of the
Compensation Committee.

Although Fabrinet pays Compensias fees, Compensia reports directly to the Compensation
Committee, and the Compensation Committee retains the authority to hire or fire Compensia and any other consultant or advisor. Compensia does not provide any services to us other than the services provided to the Compensation Committee. The
Compensation Committee has assessed the independence of Compensia taking into account, among other things, the factors set forth in Exchange Act Rule 10C-1 and the listing standards of the New York Stock Exchange, and has concluded that no conflict
of interest exists with respect to the work that Compensia performs for the Compensation Committee.

During fiscal 2016,
Compensia provided the Compensation Committee with a blend of peer group proxy data and other market data, as discussed below, to assist the Compensation Committee in evaluating the competitiveness of our executive compensation and non-employee
director compensation programs. Compensia also advised the Compensation Committee on general compensation trends in the industry among similarly situated companies.

Role of Executive Officers in Compensation Decisions

In carrying out its responsibilities, the Compensation Committee works with members of our management team, including our chief
executive officer and our chief financial officer. Typically, our management team assists the Compensation Committee in the execution of its responsibilities by providing information on corporate and individual performance and managements
perspective and recommendations on compensation matters.

Our chief executive officer typically makes recommendations to the Compensation
Committee regarding executive compensation matters. At the request of the Compensation Committee, our chief executive officer and our chief financial officer occasionally participate in meetings of the Compensation Committee, except with respect to
decisions involving their own compensation. While the Compensation Committee solicits the recommendations and proposals of our chief executive officer with respect to executive compensation matters, these recommendations and proposals are only
one factor in the Compensation Committees decision-making process.

Fiscal 2016 Peer Group and Other Market Data

To assist the Compensation Committee in evaluating whether our executive compensation practices for fiscal 2016 were
competitive and consistent with the Compensation Committees executive compensation program objectives, Compensia provided the Committee with compensation data (the Blended Market Data) consisting of an equal blend of (1) proxy
statement data from our fiscal 2016 peer group, and (2) proprietary survey data from high-tech companies with annual revenues between $500 million and $1 billion. The Compensation Committee used the Blended Market Data to compare our Named
Officers base salary, target cash incentive opportunity, target total cash compensation, equity compensation and total direct compensation against the 25th, 50th and 75th percentiles of the same categories of compensation for executives
holding positions comparable (where possible) to the positions of our Named Officers. However, the Compensation Committee does not benchmark or apply specific formulas to determine adjustments to our Named Officers base salary, target
cash incentive opportunity, target total cash compensation, equity compensation or total direct compensation.

The
specific criteria for selection into our peer group are set annually by the Compensation Committee. When our peer group is reviewed each year, companies may be removed for failure to meet the selection criteria, or new companies may be added as
necessary to ensure a significant sample size of companies. In selecting a peer group, the Compensation Committee considers companies that, in its view, compete with us for talent and have financial or other organizational metrics generally
similar to ours. Accordingly, our peer group includes a blend of businesses classified as providing either optical electronic equipment or contract manufacturing services. The selection criteria for our fiscal 2016 peer group included 12-month
trailing revenue, market capitalization, and headcount metrics. Our revenue and our market capitalization were in the 51st and 48th percentiles, respectively, of our fiscal 2016 peer group at the time the Compensation Committee selected the
group. Compensia gathered data on the compensation practices of the companies in our fiscal 2016 peer group through publicly available information, where available.

Our fiscal 2016 peer group, as approved by the Compensation Committee, consisted of the following 22 companies:

Fiscal 2016 Peer Group

Benchmark Electronics, Inc.(1)

Finisar Corporation

Newport Corporation

Black Box Corporation(1)

GSI Group

Oclaro, Inc.(1)

Calix, Inc.(1)

II-VI Incorporated(1)

OSI Systems, Inc.(1)

Ciena Corporation

Infinera Corporation

Plexus Corporation(1)

Coherent, Inc.

Methode Electronics, Inc.

Rofin Sinar Technologies, Inc.

CTS Corporation

MTS Systems

TTM Technologies, Inc.

Daktronics Inc.

Multi-Fineline Electronix, Inc.

Extreme Networks, Inc.(1)

NETGEAR, Inc.

(1)

Not part of previous fiscal years peer group.

While part of our fiscal 2015 peer group, Aeroflex Holding Corp. was removed from our fiscal 2016 peer group because it was
acquired in September 2014, and FEI Company and IPG Photonics Corporation were removed because their market capitalization exceeded our target screening criteria.

We provide a base salary to our executive officers and other employees to compensate them for services rendered on a day-to-day
basis. Following the end of each fiscal year, the Compensation Committee typically reviews and determines whether to adjust executive base salaries on the basis of each executive officers level of responsibility, qualifications,
experience, past performance and expected future contributions. The Compensation Committee also considers whether executive base salaries are competitive as compared to salary practices gathered from the Blended Market Data.

In fiscal 2016, the Compensation Committee reviewed the salary component of the Blended Market Data provided by Compensia and
considered each executive officers past performance and expected future contributions, changes in each executive officers responsibilities and organizational changes. As a result of its review, the Compensation Committee decided to
retain the same annual base salaries for fiscal 2016 as compared to fiscal 2015, as shown below.

Named Officer

Fiscal 2015 Annual BaseSalary

Fiscal 2016 Annual BaseSalary

% Change

Mr. Mitchell

$

700,000

$

700,000



Dr. Gill

$

750,000

$

750,000



Mr. Ng

$

500,000

$

500,000



Dr. Hou(1)

N/A

$

475,000



Mr. Marchetti

$

425,000

$

425,000



(1)

Dr. Hou joined us in January 2016 and, as a result, the base salary determinations that occurred in the
beginning of fiscal 2016 did not include him. However, at the time Dr. Hou joined Fabrinet, the Compensation Committee considered Dr. Hous qualifications and experience and the base salary provided by his previous employer in approving
his annual base salary of $475,000.

Short-Term Cash Incentive Awards

In August 2015, the Compensation Committee approved an executive incentive plan for fiscal 2016 (the Fiscal 2016 Bonus
Plan) that provided Mr. Mitchell, Dr. Gill, Mr. Ng and Mr. Marchetti with the ability to receive cash incentive awards based (1) 20% on achievement of individual performance objectives, (2) 40% on Fabrinets achievement of a fiscal 2016
revenue target of $840 million, and (3) 40% on Fabrinets achievement of a fiscal 2016 non-GAAP earnings per share target of $1.60, with achievement of individual objectives and each financial target considered independently from the
other. In January 2016, the Compensation Committee amended the Fiscal 2016 Bonus Plan to add Dr. Hou as a participant under the plan with the ability to receive a cash incentive award based entirely on achievement of individual performance
objectives. For purposes of the Fiscal 2016 Bonus Plan, GAAP earnings per share was adjusted for certain items. Non-GAAP earnings per share excluded share-based compensation expenses, executive separation costs, investigation costs, income
related to flooding, expenses related to reduction in workforce, amortization of debt issuance costs, unrealized gain or loss on foreign currency and a one-time cost resulting from a non-recurring warranty charge.

All of our Named Officers were eligible to participate in the Fiscal 2016 Bonus Plan, which provided for a target bonus amount
expressed as a percentage of each Named Officers base salary. The maximum bonus that each Named Officer could have received under the Fiscal 2016 Bonus Plan was two times his target bonus. Any bonus payable to Dr. Hou under the
Fiscal 2016 Bonus Plan was subject to pro-ration based on the number of months he was employed by us during fiscal 2016. Achievement of a maximum bonus payout would require significant skill and effort on the part of an executive officer and
very high levels of corporate performance that the Compensation Committee believed were possible but unlikely to be achieved. By basing a substantial portion of our executive officers total cash compensation on achievement of financial goals
designed to drive shareholder value, the Fiscal 2016 Bonus Plan was intended to align their interests with the interests of our shareholders.

The Compensation Committee determined the target bonus amount for each Named
Officer under the Fiscal 2016 Bonus Plan by considering the Blended Market Data provided by Compensia, evaluated against other criteria, including the Named Officers functional responsibilities and ongoing duties. For fiscal 2016, the
Compensation Committee approved the following target bonus amounts:

Named Officer

Fiscal 2015 Target Bonus(as a % of Base Salary)

Fiscal 2016 Target Bonus(as a % of Base Salary)

% Change

Mr. Mitchell

120

%

120

%



Dr. Gill

95

%

95

%



Mr. Ng

70

%

80

%

14.3

%

Dr. Hou

N/A

80

%



Mr. Marchetti

65

%

40

%

(38.5

)%

Under the Fiscal 2016 Bonus Plan, if we achieved 100% of a target financial metric, bonuses
were payable to our Named Officers (except Dr. Hou, whose bonus was payable based entirely on achievement of individual performance objectives) at 100% of target with respect to that financial metric component. If we achieved 90% of a target
financial metric, bonuses were payable to our Named Officers (except Dr. Hou) at 50% of target with respect to that financial metric component. If we achieved 105% or more of a target financial metric, maximum bonuses were payable to our Named
Officers (except Dr. Hou) at 200% of target with respect to that financial metric component. Achievement of the financial targets at levels between 90% and 100% and between 100% and 105% would result in a bonus amount that is scaled in a linear
fashion. In its sole discretion, the Compensation Committee determined if individual performance objectives had been met and had the ability to award up to 200% of target with respect to that component.

For fiscal 2016, we achieved (1) revenue of $976.7 million, or approximately 116.3% of our fiscal 2016 revenue target,
resulting in a bonus that was funded at 200% with respect to that component, and (2) non-GAAP earnings per share of $2.11, or approximately 131.9% of our fiscal 2016 non-GAAP earnings per share target, resulting in a bonus that was funded at 200%
with respect to that component. In addition, the Compensation Committee determined that each of Mr. Mitchell, Dr. Gill, Mr. Ng and Dr. Hou achieved certain fiscal 2016 individual performance objectives and decided to fund each of their bonuses
at 200%, 200%, 200% and 50%, respectively, with respect to that component. Accordingly, in August 2016, the Compensation Committee awarded bonuses to Mr. Mitchell, Dr. Gill, Mr. Ng and Dr. Hou under the Fiscal 2016 Bonus Plan ranging from 50%
to 200% of their respective target bonus. Amounts earned under the Fiscal 2016 Bonus Plan were paid in fiscal 2017. As Mr. Marchettis employment terminated with us on December 31, 2015, Mr. Marchetti did not receive an award under
the Fiscal 2016 Bonus Plan.

The following table describes the target, maximum and actual bonus amounts for each of our
Named Officers under the Fiscal 2016 Bonus Plan.

Named Officer

TargetBonus($)

TargetBonus(as a % ofAnnualBaseSalary)

MaximumBonus($)

MaximumBonus(as a % ofAnnualBaseSalary)

ActualBonus($)

ActualBonus(as a % ofAnnualBaseSalary)

ActualBonus(as a % ofTargetBonus)

Mr. Mitchell

840,000

120

%

1,680,000

240

%

1,680,000

240

%

200

%

Dr. Gill

712,500

95

%

1,425,000

190

%

1,425,000

190

%

200

%

Mr. Ng

400,000

80

%

800,000

160

%

800,000

160

%

200

%

Dr. Hou

190,000

(1)

80

%

380,000

(1)

160

%

95,000

20

%

50

%

Mr. Marchetti

170,000

40

%

340,000

80

%







(1)

Dr. Hou joined us in January 2016. Reflects pro-ration based on the number of months he was employed by
us during fiscal 2016. If Dr. Hou had been employed by us for all of fiscal 2016, his target bonus would have been $380,000 and his maximum bonus would have been $760,000.

Our equity incentive plan is a critical component of the compensation program that we believe incentivizes our executive
officers and key employees to focus on building shareholder value through meeting long-term financial and strategic goals. We grant restricted share units (RSUs) to our executive officers and other employees under our 2010 Performance
Incentive Plan. RSUs also function as a retention incentive for our executives as they generally vest annually over a four-year period after the date of grant. Beginning in fiscal 2015, the Compensation Committee adopted a practice of
granting RSUs to our executive officers that is based, in part, on Fabrinet achieving a financial performance goal. In fiscal 2016, the Compensation Committee continued this practice, as described below.

The Compensation Committee bases long-term equity incentive award grants to executives on a number of factors, including the
Blended Market Data provided by Compensia, the executives vested and unvested equity holdings, the executives position and total compensation package, and the executives contribution to the success of our financial performance.

In August 2015, the Compensation Committee approved a long-term equity plan for fiscal 2016 (the Fiscal 2016 LTE
Plan), which provided for the grant of non-performance-based RSUs to our Named Officers (except Mr. Marchetti) following the completion of fiscal 2016, the amount of which could be increased based on performance during fiscal 2016, as
described below. In January 2016, the Compensation Committee amended the Fiscal 2016 LTE Plan to add Dr. Hou as a participant under the plan. Under the Fiscal 2016 LTE Plan, a minimum dollar value of non-performance-based RSUs would be granted to
each Named Officer (except Mr. Marchetti), regardless of our fiscal 2016 revenue results. The minimum number of shares to be granted under each such RSU award would be equal to the minimum dollar value of the participants award, divided
by the fair market value per share of our ordinary shares on the grant date, with the quotient rounded down to the nearest whole share.

The Fiscal 2016 LTE Plan also provided for the grant of an additional target value of performance-based RSUs to our Named
Officers (except Mr. Marchetti), as follows:



If we achieved the fiscal 2016 revenue target of $840 million, a target dollar value of performance-based RSUs
would be granted to Mr. Mitchell, Dr. Gill and Mr. Ng.



If we achieved 90% of the fiscal 2016 revenue target (i.e., $756 million), 50% of the target dollar value of
performance-based RSUs would be granted to Mr. Mitchell, Dr. Gill and Mr. Ng.



If we achieved 105% or more of the fiscal 2016 revenue target (i.e., $882 million or more), 200% of the target
dollar value of performance-based RSUs would be granted to Mr. Mitchell, Dr. Gill and Mr. Ng.



Achievement of the fiscal 2016 revenue target at levels between 90% and 100% and between 100% and 105% would
result in a dollar value of performance-based RSUs being granted to Mr. Mitchell, Dr. Gill and Mr. Ng that is scaled in a linear fashion.



If Dr. Hou achieved his individual performance objectives, a target dollar value of RSUs would be granted to
Dr. Hou.



The number of shares to be granted under each such performance-based RSU award would be equal to the actual
dollar value of the Named Officers award, divided by the higher of (i) the fair market value per share of our ordinary shares on the grant date, or (ii) $10.00, with the quotient rounded down to the nearest whole share.

For fiscal 2016, we achieved revenue of $976.7 million, or approximately 116.3% of our fiscal 2016
revenue target, resulting in the aggregate maximum dollar value of RSUs (non-performance and performance-based) being awarded to Mr. Mitchell, Dr. Gill and Mr. Ng. In addition, the Compensation Committee

determined that Dr. Hou achieved half of his fiscal 2016 individual performance objectives, resulting in a dollar value of RSUs being awarded to Dr. Hou at 75% of the aggregate target dollar
value of RSUs (non-performance and performance-based) for Dr. Hou. RSUs earned under the Fiscal 2016 LTE Plan were granted under our 2010 Performance Incentive Plan in the first quarter of fiscal 2017, but are reported as compensation for
fiscal 2016 in the Summary Compensation Table.

The following table sets forth the minimum, target, maximum
and actual dollar value of RSUs for our Named Officers under the Fiscal 2016 LTE Plan, as well as the percentage of RSUs that were awarded under the plan based on performance.

RSUs were granted in fiscal 2017, but are reported as compensation for fiscal 2016 in the Summary
Compensation Table. RSUs vest over a four-year period at a rate of 25% on each anniversary of the grant date, subject to the Named Officers continued employment or other service and the terms of the executives employment
agreement or offer letter, as applicable.

In April 2016, in connection with the commencement of Dr.
Hous employment, the Compensation Committee granted RSUs to Dr. Hou as set forth in the table below. The Compensation Committee considered Dr. Hous qualifications and experience and equity awards granted by his previous employer in
approving the grant of such RSUs.

Named Officer

Grant Date

Number of RSUs(#)

Grant Date Fair Value($)

Dr. Hou

4/28/2016

36,591

1,189,939

During fiscal 2016, the Compensation Committee also granted RSUs to certain of our Named
Officers pursuant to our fiscal 2015 performance share unit plan, as described in our 2015 proxy statement. The grant date fair value of such awards is reported in the Stock Awards column of the Summary Compensation
Table for fiscal 2015 because the awards were earned in fiscal 2015. See the Grants of Plan-Based Awards in Fiscal 2016 table for more information.

Perquisites and Personal Benefits

In addition to base salaries, we provide our Named Officers with certain perquisites and personal benefits. We believe that
perquisites and personal benefits are a tax-advantaged way to provide our Named Officers with additional annual compensation that supplements their base salaries. We do not establish the value of each Named Officers perquisites and personal
benefits in a vacuum or as some form of compensation add on. Instead, we view the value of the perquisites as another component of annual compensation that is merely paid in a different form. When determining each Named
Officers base salary, we take the value of each Named Officers perquisites and personal benefits into consideration.

We provide certain benefits and allowances to our international assignees,
including our Named Officers, which include housing and transportation allowances, living and travel expense reimbursements and tax preparation services. Consistent with the policy we have adopted with respect to all U.S. citizens who are
working on our behalf in Asia on an expatriate basis, we pay such employees a tax equalization payment that is intended to put the employee in the same position, from a tax-liability perspective, that he or she would be in if they were still located
in the United States. Of our Named Officers, Mr. Mitchell, Dr. Gill and Mr. Ng receive a tax equalization payment because each qualifies for such benefit under the policy.

In addition, in October 2014, the Compensation Committee approved the payment of additional cash compensation to Dr. Gill
and Mr. Ng in the amount of 20% of their respective then-current annual base salary, determined and payable bi-monthly, with a tax gross-up (the Foreign Service Premium Pay), to incentivize them to continue working for us in
Thailand and to ameliorate the resulting hardships to their families who are located in the United States. The Foreign Service Premium Pay was deemed effective as of July 1, 2014, and will continue for as long as Dr. Gill and Mr. Ng
are required to, and do, temporarily reside and work in Thailand. In January 2015, the Compensation Committee authorized the purchase of key man life insurance policies for each of Dr. Gill and Mr. Ng, which provides for $3 million payable to
the applicable Named Officers elected beneficiaries and $2 million payable to us. Dr. Gill and Mr. Ng also receive a family travel benefit that provides each of their immediate family members a round-trip airline ticket to visit Thailand
once per year at our expense.

In October 2016, we reviewed executive perquisites and adopted a perquisite policy that
excludes non-business, travel-related expenses and charitable contributions.

The perquisites and personal benefits paid
to each Named Officer in fiscal 2016 are reported in the All Other Compensation column of the Summary Compensation Table below, and are further described in the footnotes to such table.

Severance and Other Benefits Upon Termination of Employment

We and certain of our subsidiaries have entered into employment agreements or offer letters with our Named Officers that
provide for them to receive severance benefits following certain terminations of their employment with us or our subsidiaries, as applicable. These arrangements are consistent with our overall compensation objectives because we believe such
arrangements are critical to achieve our business objective of management retention. We evaluate the level of severance benefits to provide a Named Officer on a case-by-case basis. To ensure that the severance and change of control
arrangements continue to remain consistent with our compensation philosophy and current market practices, the Compensation Committee may periodically review these arrangements. Please see Potential Payments Upon Termination or Change in
Control below, for a description of the severance benefits our Named Officers may be entitled to receive upon termination of their employment.

Share Ownership Guidelines

To further align the interests of our executive officers and members of our Board of Directors with those of our shareholders,
we have adopted share ownership guidelines for our executive officers and directors, which provide for a minimum ownership level equal to:



chief executive officer6x annual base salary;



other executive officers2x annual base salary; and



directors3x annual Board retainer.

Executive officers and directors are expected to meet these ownership levels within five years from August 2012 or, if
appointed or elected after August 2012, within five years of their appointment as an executive officer

or election to the Board of Directors. Shares counted towards the minimum ownership levels include all shares beneficially owned by the executive officer or director and any unvested
restricted share units held by the executive officer or director. All of our current executive officers and directors currently exceed their respective share ownership guidelines.

Hedging Policy

We have an insider trading policy that prohibits, among other things, short sales, hedging of stock ownership positions, and
transactions involving derivative securities relating to our ordinary shares.

Tax Considerations

Section 162(m) of the Internal Revenue Code places a limit of $1 million per year on the U.S. corporate income tax
deduction a publicly-held corporation may take for compensation paid to each of its covered employees (generally, the chief executive officer and the next three most highly compensated executive officers, other than the chief financial
officer, as of the end of any fiscal year). In general, certain performance-based compensation approved by shareholders is not subject to this $1 million deduction limit. Prior to our initial public offering, our Board of Directors did not take
the deductibility limit imposed by Section 162(m) into consideration in making compensation decisions. In the future, the Compensation Committee may adopt a policy that, where reasonably practicable, we will seek to qualify the compensation
paid to Named Officers that are employees of our U.S.-based subsidiaries as performance-based compensation to participate in the exemption from the deductibility limitations of Section 162(m). However, the Compensation Committee may
continue to authorize compensation payments that do not comply with the exemptions in Section 162(m) when it believes that such payments are appropriate to attract and retain executive talent.

Compensation Recovery Policy

In October 2016, we adopted a clawback policy applicable to our executive officers. If a majority of the independent members of
the Board of Directors determines that an officers misconduct caused us to materially restate all or a portion of our financial statements, the Board may require the officer to repay incentive compensation that would not have been payable
absent the material restatement. This policy applies to all incentive compensation, excluding equity awards granted prior to the adoption of the policy, based on financial statements filed during the three years prior to the material restatement.
The Compensation Committee intends to revisit our clawback policy after the SEC adopts final rules implementing the requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act.

Compensation and Risk Assessment

The Compensation Committee has assessed the risks associated with our compensation policies and practices for all employees
and, based on its assessment, does not believe that such compensation policies and practices create risks that are reasonably likely to have a material adverse effect on us.

Compensation Committee Report

The Compensation Committee oversees Fabrinets compensation policies, plans and benefit programs. The Compensation
Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with management. Based on such review and discussions, the Compensation Committee has recommended to the Board of
Directors that the Compensation Discussion and Analysis be included in this proxy statement.

Respectfully submitted by
the members of the Compensation Committee of the Board of Directors.

The following table presents information regarding the total compensation of our Named Officers, who include (i) our principal
executive officer, (ii) our principal financial officer, (iii) our other most highly compensated executive officers, other than our principal executive officer and principal financial officer, who were serving as executive officers at the end of
fiscal 2016, and (iv) a former executive officer for whom disclosure would have been provided pursuant to Item 402 of Regulation S-K but for the fact that the individual was not serving as an executive officer at the end of fiscal 2016.

The amounts in this column represent the aggregate grant date fair value computed in accordance with FASB ASC
Topic 718. The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10-K for our fiscal year ended June 24, 2016, filed with
the SEC on August 17, 2016. These amounts do not necessarily correspond to the actual value that may be recognized by the Named Officer.

(2)

For fiscal 2016, except as otherwise noted, the amounts in this column reflect the grant date fair value of
stock awards earned under our fiscal 2016 long-term equity plan; such stock awards are reported as compensation for fiscal 2016 but were granted in fiscal 2017. For fiscal 2015, a portion of the amounts in this column reflect the grant date
fair value of stock awards earned under our fiscal 2015 performance share unit plan; such stock awards are reported as compensation for fiscal 2015 but were granted in fiscal 2016. For fiscal 2014, the amounts in this column reflect the grant
date fair value of stock awards granted in fiscal 2014. For more information, see the Grants of Plan-Based Awards in Fiscal 2016 table below.

For more information, see the All Other Compensation for Fiscal 2016 table below.

(5)

Dr. Hou joined Fabrinet in January 2016. Accordingly, only information for fiscal 2016 is provided with
respect to Dr. Hou.

(6)

Also includes restricted share units with a grant date fair value of $1,189,939 that were awarded to Dr. Hou
in April 2016 in connection with him joining Fabrinet.

(7)

In August 2015, Mr. Marchetti resigned as Executive Vice President, Chief Strategy Officer of Fabrinet USA,
Inc., effective as of December 31, 2015.

All Other Compensation for Fiscal 2016

Name

Transportation($)(1)

Housing($)(2)

TaxEqualizationPayment($)(3)

ForeignServicePremiumPay($)(4)

HealthInsurancePremiums($)

Term LifeInsurancePremiums($)

401(k)Contributions($)

Other($)

Total($)

Mr. Mitchell

424,693

294,468

166,569



32,003





104,116

(5)

1,021,849

Dr. Gill

47,477

120,000

207,473

150,000

28,940

26,280

13,469

55

(6)

593,694

Mr. Ng

49,479

120,000

246,916

100,000

28,940

30,075

14,550



589,960

Dr. Hou

6,000







15,706



9,552



31,259

Mr. Marchetti

6,000







18,515



263

1,758,093

(7)

1,782,871

(1)

For Mr. Mitchell, represents (i) $269,231 of hotel expenses, (ii) $108,640 of airfare expenses, (iii) $45,232
of automobile expenses, and (iv) $1,590 of additional expenses for guests traveling with him. For Dr. Gill, represents (i) an annual travel allowance $25,000, (ii) an annual automobile allowance of $12,000, and (iii) $10,477 of expenses related to a
car and driver in Thailand. For Mr. Ng, represents (i) an annual travel allowance $15,000, (ii) an annual automobile allowance of $12,000, and (iii) $22,479 of expenses related to a car and driver in Thailand. For Dr. Hou and Mr.
Marchetti, represents an automobile allowance.

(2)

For Mr. Mitchell, represents rent expense, utilities and home services. For Dr. Gill and Mr. Ng,
represents an annual allowance for housing and related living expenses in Thailand.

(3)

Represents foreign tax liability payments by Fabrinet on the Named Officers behalf to satisfy all
applicable non-U.S. taxes of such Named Officer for the following calendar years: Mr. Mitchell and Dr. Gillcalendar year 2014; Mr. Ngcalendar year 2015. Consistent with corporate policy, we pay on behalf of all U.S. citizens who are
working on our behalf in Asia on an expatriate basis a tax equalization payment that is intended to put the employee in the same position, from a tax-liability perspective, that he or she would be in if they were still located in the United States.

(4)

Represents additional cash compensation in the amount of 20% of Dr. Gill and Mr. Ngs respective
then-current annual base salary, with a tax gross-up, to incentivize them to continue working for us in Thailand and ameliorate the resulting hardships to their families who are located in the United States.

(5)

Represents (i) $35,742 of expenses associated with Mr. Mitchells home office in the United States,
(ii) $43,986 of out-patient medical expenses, (iii) $21,705 of expenses for meals, and (iv) $2,683 of charitable donations made on Mr. Mitchells behalf.

Mr. Marchetti left Fabrinet in December 2015. As severance compensation, he received (i) a lump sum cash
payment in the amount of $425,000, (ii) a lump sum cash payment in the amount of $138,000, in lieu of the amount of bonus Mr. Marchetti would have received under the fiscal 2016 executive incentive plan based on proration and assumed Company
performance through the second quarter of fiscal 2016, (iii) reimbursement in the amount of $76,225 for health care insurance premiums under COBRA, (iv) reimbursement in the amount of $108,520 for outplacement services and office expenses, (v)
accelerated vesting with respect to an aggregate of 40,613 restricted share units ($961,310 based on the closing price of our ordinary shares on the vesting date), and (vi) payment of accrued vacation in the amount of $49,038.

Grants of Plan-Based Awards in Fiscal 2016

The following table presents information concerning each grant of an award made to a Named Officer in fiscal 2016 under any
plan.

Name

GrantDate

Estimated Possible PayoutsUnder Non-Equity IncentivePlan Awards(1)

Estimated Possible PayoutsUnder Equity Incentive PlanAwards(2)(3)

All OtherStockAwards:Number ofShares ofStock orUnits(#)

All OtherOptionAwards:Number ofSecuritiesUnderlyingOptions(#)

Exerciseor BasePrice ofOptionAwards($/Sh)

Grant DateFair Valueof Stock andOptionAwards($)(4)

Threshold($)

Target($)

Maximum($)

Threshold($)

Target($)

Maximum($)

Mr. Mitchell





840,000

1,680,000























1,730,000

3,460,000

5,190,000









8/20/2015













164,717





3,211,982

(5)

Dr. Gill





712,500

1,425,000























575,000

1,150,000

1,725,000









8/20/2015













60,256





1,174,992

(5)

Mr. Ng





400,000

800,000























550,000

1,100,000

1,650,000









8/20/2015













55,076





1,073,982

(5)

Dr. Hou





190,000

380,000























250,000

500,000

500,000









4/28/2016













36,591





1,189,939

Mr. Marchetti





170,000

340,000















8/20/2015













29,282





570,999

(5)

(1)

Reflects target and maximum cash incentive award amounts for fiscal 2016 performance under our fiscal 2016
executive incentive plan, as described in Compensation Discussion and AnalysisExecutive Compensation Program ElementsShort-Term Cash Incentive Awards. There is no threshold payout amount under the fiscal 2016 executive
incentive plan, as the minimum amount payable under the plan is $0. The actual bonus amounts were determined by the Compensation Committee in August 2016 and are reflected in the Non-Equity Incentive
Plan Compensation column of the Summary Compensation Table.

(2)

Reflects the dollar value of threshold, target and maximum equity awards for fiscal 2016 performance under
our fiscal 2016 long-term equity plan, which provides for awards of restricted share units based, in part, on the achievement of a corporate performance objective. Restricted share units awarded under our fiscal 2016 long-term equity plan vest
over a four-year period at a rate of 25% on each anniversary of the vesting commencement date. Our fiscal 2016 long-term equity plan is described more fully above in Compensation Discussion and AnalysisExecutive Compensation Program
ElementsLong-Term Equity Incentive Awards.

(3)

In August 2016, the Compensation Committee determined the actual dollar value of awards earned by our Named
Officers under our fiscal 2016 long-term equity plan and granted the following number of restricted share units to each Named Officer, as determined by dividing (i) the dollar value attributable to the Named Officers actual bonus under
the plan by (ii) the closing price per share of our ordinary shares on the New York Stock Exchange on the date of grant, rounded down to the nearest whole share. These amounts are included in the Stock Awards column of the
Summary Compensation Table for fiscal 2016.

Reflects the aggregate grant date fair value of each equity award computed in accordance with FASB ASC Topic
718. The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10-K for the fiscal year ended June 24, 2016, filed with the SEC on
August 17, 2016. These amounts do not necessarily correspond to the actual value that may be recognized by the Named Officer.

(5)

Although this restricted share unit award was granted in fiscal 2016, the grant date fair value is reported
in the Stock Awards column of the Summary Compensation Table for fiscal 2015 because the award was earned in fiscal 2015 under our fiscal 2015 performance share unit plan.

Outstanding Equity Awards at Fiscal 2016 Year-End

The following table presents information regarding the outstanding equity awards held by each Named Officer as of the end of
fiscal 2016.

Option Awards

Stock Awards

GrantDate(1)

Number of Securities UnderlyingUnexercised Options (#)

OptionExercisePrice($)

OptionExpirationDate(2)

Number ofShares orUnits ofStock ThatHave NotVested(#)

MarketValue ofShares orUnits ofStock ThatHave NotVested($)(3)

Name

Exercisable

Unexercisable

Mr. Mitchell

10/13/2010

225,000



16.83

10/13/2017





11/10/2011

129,828



14.12

11/9/2018





8/23/2012

(4)









16,368

572,389

11/8/2012

(4)









16,667

582,845

8/9/2013

(4)









50,000

1,748,500

8/14/2013

(4)









10,000

349,700

10/19/2014

(4)









124,275

4,345,897

8/20/2015

(4)









164,717

5,760,153

Dr. Gill

8/23/2012









10,229

357,708

11/8/2012









10,417

364,282

8/9/2013









37,500

1,311,375

10/19/2014









68,250

2,386,703

8/20/2015









60,256

2,107,152

Mr. Ng

10/13/2010

22,500



16.83

10/13/2017





11/10/2011

21,638



14.12

11/9/2018





3/1/2012

5,550



18.60

2/28/2019





8/23/2012









4,093

143,132

11/8/2012









4,167

145,720

8/9/2013









20,000

699,400

10/19/2014









38,250

1,337,603

8/20/2015









55,076

1,926,008

Dr. Hou

4/28/2016









36,591

1,279,587

Mr. Marchetti















(1)

All options vested over a four-year period at a rate of 1/48th per month. Stock awards consist of
restricted share units. Unless otherwise noted, all restricted share units vest over a four-year period at a rate of 25% on each anniversary of the vesting commencement date.

The expiration date shown is the normal expiration date and the latest date that options may be exercised.
Options may terminate earlier in certain circumstances, such as in connection with a Named Officers termination of employment or in connection with a change in control.

(3)

Market value of shares or units of stock that have not vested is computed by multiplying (i) $34.97, the
closing price on the New York Stock Exchange of our ordinary shares on June 24, 2016, the last business day of fiscal 2016, by (ii) the number of shares or units of stock.

(4)

Pursuant to Mr. Mitchells amended and restated employment agreement dated May 25, 2015, as amended,
provided that Mr. Mitchells employment with us continues through and on February 20, 2017, Mr. Mitchell shall become 100% vested on February 20, 2017, in such restricted share unit award.

Option Exercises and Shares Vested in Fiscal 2016

The following table presents information concerning the exercise of options and the vesting of stock awards in fiscal 2016 for
each of our Named Officers.

Option Awards

Stock Awards

Name

Number ofShares Acquiredon Exercise(#)

Value Realizedon Exercise($)(1)

Number ofShares Acquiredon Vesting(#)

Value Realized onVesting($)(2)

Mr. Mitchell





120,932

2,373,805

Dr. Gill

103,555

1,893,081

70,998

1,397,076

Mr. Ng





34,335

673,087

Mr. Hou









Mr. Marchetti

20,818

275,422

71,321

1,546,342

(1)

The value realized on exercise was determined by multiplying (i) the number of our ordinary shares
acquired upon exercise of a share option, by (ii) the difference between the closing price per share of our ordinary shares on the New York Stock Exchange on the date of exercise and the exercise price of the share option.

(2)

The value realized on vesting was determined by multiplying (i) the number of our ordinary shares
acquired upon vesting of a restricted share unit, by (ii) the closing price per share of our ordinary shares on the New York Stock Exchange on the vesting date.

Potential Payments Upon Termination or Change of Control

We and certain of our subsidiaries have entered into employment agreements or offer letters with our Named Officers that
provide the general terms and conditions of their employment, including payments and benefits upon termination of their employment in specified circumstances, including a change in control of the Company.

Arrangement with Mr. Mitchell

We have entered into an employment agreement with Mr. Mitchell, which provides for a term of employment through and including
March 2, 2022, unless extended by mutual agreement or terminated prior to such date. Mr. Mitchell may terminate his employment with us for any reason by providing written notice 90 days in advance. We may terminate Mr. Mitchells
employment at any time with or without notice or cause. Under the employment agreement, Mr. Mitchell is entitled to certain payments upon termination of employment as described below.

In the event Mr. Mitchells employment is terminated due to death, Mr. Mitchells legal representatives or
named beneficiaries will receive a lump sum payment in an amount equal to the sum of (i) twenty-four

(24) months of Mr. Mitchells then current base salary, and (ii) an amount equal to the pro-rata portion of the target bonus which Mr. Mitchell would have been paid for
his performance for the fiscal year in which his death occurs, but in no event less than six (6) months of Mr. Mitchells then current base salary, and such payments shall be made upon the sixtieth (60) day following
Mr. Mitchells death. Additionally, Mr. Mitchells legal representatives or named beneficiaries will receive continued tax equalization benefits under our expatriate policy, as in effect on the date of termination, for the
calendar year in which the termination date occurs and the following calendar year.

In the event Mr. Mitchells
employment is terminated due to disability, Mr. Mitchell will be eligible to receive a lump sum payment in an amount equal to twenty-four (24) months of his then current base salary. Additionally, Mr. Mitchell will receive continued
tax equalization benefits under our expatriate policy, as in effect on the date of Mr. Mitchells disability, for the calendar year in which the disability occurs and the following calendar year.

In the event Mr. Mitchells employment is terminated prior to February 20, 2022 (the Mitchell Transition
Date) either by us without good cause or by Mr. Mitchell for good reason, Mr. Mitchell will (A) be eligible to receive a lump sum payment equal to the sum of (i) twenty-four (24) months of his
then current base salary, and (ii) any earned but unpaid bonus as of the date of termination of employment; (B) be eligible to receive a lump sum payment equal to two times his cost of COBRA coverage for twelve months; and (C) receive
continued tax equalization benefits under our expatriate policy, as in effect on the date of termination, for the calendar year in which the termination date occurs and the following calendar year.

In the event Mr. Mitchell terminates his employment on the Mitchell Transition Date or within ten (10) calendar days
after the Mitchell Transition Date, Mr. Mitchell will (A) be eligible to receive a lump sum payment equal to the sum of (i) the product of one months base salary then in effect multiplied by the total number of full and
fractional years of his employment with us as of his termination date, and (ii) any earned but unpaid bonus as of the date of termination of employment, (B) be eligible to receive a lump sum payment equal to two times his cost of COBRA
coverage for twelve months, and (C) receive continued tax equalization benefits under our expatriate policy, as in effect on the date of termination, for the calendar year in which the termination date occurs and the following calendar year
(collectively, the Retention Benefits). Except as otherwise provided in the Employment Agreement, in the event Mr. Mitchells employment is terminated prior to the Mitchell Transition Date or more than ten (10) calendar
days after the Mitchell Transition Date, no Retention Benefits shall be due, owed, or paid to him.

Notwithstanding any
statement contained in the employment agreement to the contrary, in the event Mr. Mitchells employment is terminated on account of death or disability, by us without good cause, by Mr. Mitchell for good
reason, or by Mr. Mitchell on the Mitchell Transition Date or within ten (10) calendar days after the Mitchell Transition Date, (x) any Acceleration Eligible Awards that are options or rights to purchase Fabrinet
securities shall immediately vest and remain exercisable until the earlier of (1) the four (4) year anniversary of the date of Mr. Mitchells termination or disability, or (2) the date on which the options or rights to
purchase Fabrinet securities otherwise would have expired in accordance with their terms, and (y) Mr. Mitchell will become 100% vested immediately prior to the termination or disability date in any Acceleration Eligible Awards
that are outstanding restricted stock, restricted share units, stock appreciation rights, phantom stock or other equity based awards, which have not previously fully vested.

The employment agreement provides for non-solicitation covenants for 12 months following a termination or resignation of
employment that would result in the severance payments described above, as well as customary confidentiality covenants for the term of employment and thereafter.

Acceleration Eligible Award means (i) any restricted stock, restricted share units, stock appreciation rights,
phantom stock or other equity based awards granted prior to August 1, 2016 and (ii) the award of restricted share units that was granted in August 2016 pursuant to Fabrinets Fiscal 2016 Long-Term Equity Plan as a result of the Compensation
Committees determination that the applicable fiscal year 2016 performance criteria had been achieved under such plan.

Good cause means Mr. Mitchells (i) commission of any felony or
any crime involving moral turpitude, (ii) willful breach of his duties to us, including, but not limited to, theft from us and failure to fully disclose personal pecuniary interest in a transaction involving us, or (iii) engaging in willful
misconduct, willful or gross neglect, fraud, misappropriation, or embezzlement, in each case in the performance of his duties.

Good reason means (i) a material diminution during the term of the agreement in Mr. Mitchells office,
duties, or responsibilities (including following any change in control) or (ii) a material breach by us of the agreement. However, before terminating his employment for good reason, Mr. Mitchell must provide (i) reasonable written notice to our
Board of Directors setting forth the reasons for his intention to terminate for good reason and (ii) an opportunity for our Board of Directors to meet with him, together with legal counsel, and cure such reason within 30 days after receipt of such
notice.

Arrangements with Dr. Gill and Mr. Ng

In the event Dr. Gills or Mr. Ngs employment is terminated prior to May 7, 2018 (the Gill
Transition Date), in the case of Dr. Gill, or prior to December 30, 2018 (the Ng Transition Date), in the case of Mr. Ng, either by Fabrinet USA, Inc. without good cause or by Dr. Gill or Mr. Ng, as
applicable, for good reason, Dr. Gill and Mr. Ng, as applicable, will (A) be eligible to receive a lump sum payment equal to the sum of (i) twelve (12) months of his then present base salary, and (ii) any earned
but unpaid bonus as of the date of termination of employment; (B) be eligible to receive a lump sum payment equal to two times his cost of COBRA coverage for twelve months; (C) become 100% vested immediately prior to his termination date
in any outstanding stock options, restricted stock, restricted share units, stock appreciation rights, phantom stock or other equity based awards (collectively, the Equity Awards), which have not previously fully vested; and
(D) receive continued tax equalization benefits under our expatriate policy, as in effect on the date of termination, for the calendar year in which the termination date occurs, and the following calendar year. Notwithstanding the foregoing,
the vesting acceleration benefit specified in subsection (C) (the Vesting Acceleration Benefit) shall apply only to (x) Equity Awards granted to Dr. Gill or Mr. Ng, as applicable, before August 1, 2016 and (y) the Equity Award of
restricted share units that was granted in August 2016 pursuant to Fabrinets Fiscal 2016 Long-Term Equity Plan (the FY16 LTE RSU Grant) as a result of the Compensation Committees determination that the applicable fiscal year
2016 performance criteria had been achieved under such plan.

In the event Dr. Gill terminates his employment on the
Gill Transition Date or within ten (10) calendar days after the Gill Transition Date, or Mr. Ng terminates his employment on the Ng Transition Date or within ten (10) calendar days after the Ng Transition Date, Dr. Gill and Mr.
Ng, as applicable, will be eligible to receive (1) a lump sum payment equal to the product of one months base salary multiplied by the total number of full and fractional years of his employment with Fabrinet USA, Inc. as of his
termination date, and (2) all of the payments and benefits described in subsections (B), (C) and (D) of the preceding paragraph (collectively, the Retention Benefits). Notwithstanding the foregoing, the Vesting
Acceleration Benefit shall apply only to (x) Equity Awards granted to Dr. Gill or Mr. Ng, as applicable, before August 1, 2016 and (y) the FY16 LTE RSU Grant. In the event Dr. Gills employment is terminated prior to the Gill
Transition Date or more than ten (10) calendar days after the Gill Transition Date, no Retention Benefits shall be due, owed, or paid to him. In the event Mr. Ngs employment is terminated prior to the Ng Transition Date or more
than ten (10) calendar days after the Ng Transition Date, no Retention Benefits shall be due, owed, or paid to him.

In the event Dr. Gills or Mr. Ngs employment is terminated on account of death or disability prior to the
Gill Transition Date or the Ng Transition Date, as applicable, he will become 100% vested immediately prior to the termination date in any outstanding Equity Awards, which have not previously fully vested. Notwithstanding the foregoing, such vesting
acceleration shall apply only to (x) Equity Awards granted to Dr. Gill or Mr. Ng, as applicable, before August 1, 2016 and (y) the FY16 LTE RSU Grant.

For purposes of Dr. Gills and Mr. Ngs employment arrangements, good cause means (i) an act of
dishonesty made in connection with their responsibilities as an employee, (ii) a conviction of or plea of nolo

contendere to a felony or any crime involving fraud, embezzlement or any other act of moral turpitude, (iii) gross misconduct, (iv) unauthorized use or disclosure of any proprietary information
or trade secrets of the Company or any other party to whom they owe an obligation of nondisclosure, (v) willful breach of any obligations under any written agreement or covenant with the Company, or (vi) continued failure to perform employment
duties after receipt of a written demand for performance from the Company.

For purposes of Dr. Gills and Mr.
Ngs employment arrangements good reason means the occurrence of any of the following events, without their consent: (i) a material diminution in base compensation; (ii) a material diminution in authority, duties, or
responsibilities; (iii) a material change in the geographic location at which they must perform services for us; or (iv) any other action or inaction that constitutes a material breach by us of any written agreement or covenant with us.
However, before terminating employment for good reason, Dr. Gill and Mr. Ng, as applicable, must provide (i) written notice to us setting forth the reasons for his intention to terminate for good reason and (ii) an opportunity for us to remedy the
condition within 30 days after receipt of such notice.

Arrangement with Dr. Hou

In the event Dr. Hous employment is terminated either by Fabrinet USA, Inc. without good cause or by
Dr. Hou for good reason, Dr. Hou will (A) be eligible to receive a lump sum payment equal to the sum of (i) twelve (12) months of his then present base salary, and (ii) any earned but unpaid bonus as of the
date of termination of employment; (B) be eligible to receive a lump sum payment equal to two times his cost of COBRA coverage for twelve months; and (C) become 100% vested immediately prior to his termination date in any outstanding stock
options, restricted stock, restricted share units, stock appreciation rights, phantom stock or other equity based awards, which have not previously fully vested.

In the event Dr. Hou terminates his employment on account of retirement, he will be eligible to receive (1) a lump
sum payment equal to the product of one months base salary multiplied by the total number of full and fractional years of his employment with Fabrinet USA, Inc. as of his termination date, and (2) all of the payments and benefits
described in subsections (B), (C) and (D) of the preceding paragraph (collectively, the Retention Benefits).

For purposes of Dr. Hous employment arrangement, good cause means (i) an act of dishonesty made in
connection with his responsibilities as an employee, (ii) a conviction of or plea of nolo contendere to a felony or any crime involving fraud, embezzlement or any other act of moral turpitude, (iii) gross misconduct, (iv) unauthorized use or
disclosure of any proprietary information or trade secrets of the Company or any other party to whom he owes an obligation of nondisclosure, (v) willful breach of any obligations under any written agreement or covenant with the Company, or (vi)
continued failure to perform employment duties after receipt of a written demand for performance from the Company.

For
purposes of Dr. Hous employment arrangement, good reason means the occurrence of any of the following events, without his consent: (i) a material diminution in base compensation; (ii) a material diminution in authority,
duties, or responsibilities; (iii) a material change in the geographic location at which he must perform services for us; or (iv) any other action or inaction that constitutes a material breach by us of any written agreement or covenant
with us. However, before terminating employment for good reason, Dr. Hou must provide (i) written notice to us setting forth the reasons for his intention to terminate for good reason and (ii) an opportunity for us to remedy the condition within 30
days after receipt of such notice.

For purposes Dr. Hous employment arrangement, retirement means his
voluntary termination of employment (i) on or after attainment of age 65, and (ii) after a successor to his position assumes his position that is satisfactory to the Companys board of directors.

We provide each of Dr. Gill and Mr. Ng with a life insurance policy, which in the event of death would pay $3 million to
their respective heirs or beneficiaries and $2 million to us.

The following table provides information concerning the
estimated payments and benefits that would be provided to Mr. Mitchell, Dr. Gill and Mr. Ng in the circumstances described above. Payments and benefits are estimated assuming the triggering event took place on the last business day of fiscal
2016 (June 24, 2016). There can be no assurance a triggering event would produce the same or similar results as those estimated below if such event occurs on any other date, of if any other assumption used to estimate potential payments and
benefits is not correct. Due to the number of factors affecting the nature and amount of any potential payments or benefits, any actual payments and benefits may be different.

Potential Payments Upon Termination of Employment(Whether or Not
in Connection With a Change ofControl):

Potential Payments Upon Termination of Employment(Whether or Not in Connection With a Change ofControl):

Name

Type of Benefit

Due to Death ($)

Due to Disability ($)

WithoutCause ($)

Due toResignationfor GoodReason ($)

Dr. Hou

Cash Severance Payment100% Annual Base Salary(1)





475,000

475,000

Cash Severance PaymentCash Incentive Plan Compensation





95,000

95,000

Equity Award Vesting100% Acceleration(2)





1,279,587

1,279,587

Continued Coverage of Medical Benefits(3)





60,000

60,000

Total Value of Termination Benefits(4)





1,909,587

1,909,587

(1)

Assumes an annual base salary of $700,000 for Mr. Mitchell, $750,000 for Dr. Gill, $500,000 for Mr. Ng, and
$475,000 for Dr. Hou (salaries in effect at June 24, 2016).

(2)

Potential value if vesting of all unvested options and RSUs as of June 24, 2016 had been accelerated. Assumes
a share price of $34.97 (based on the closing price per share of our ordinary shares on June 24, 2016).

(3)

Reflects two times the annual cost of COBRA coverage to maintain the benefits currently provided.

(4)

Does not include the future tax equalization benefits that such Named Officer is entitled to under our
expatriate policy, as described above in Executive CompensationCompensation Discussion and Analysis.

(5)

Reflects the death benefit payable to the executives estate in the case of the executives death.

Separation Agreement with Mr. Marchetti

In August 2015, John Marchetti resigned as Executive Vice President, Chief Strategy Officer of Fabrinet USA, Inc., effective as
of December 31, 2015. In connection with Mr. Marchettis resignation, on September 29, 2015, Fabrinet USA, Inc. and Fabrinet entered into a separation agreement and release with Mr. Marchetti. As consideration for non-disparagement
obligations to Fabrinet USA, Inc. and Fabrinet and a full release of all claims related to Mr. Marchettis employment with Fabrinet USA, Inc., Mr. Marchetti received: (1) a lump sum cash payment in the amount of $425,000; (2) a lump sum cash
payment in the amount of $138,000, in lieu of the amount of bonus Mr. Marchetti would have received under the Companys Fiscal 2016 Executive Incentive Plan based on proration and assumed Company performance through the second quarter of fiscal
2016; (3) reimbursement for health care insurance premiums under COBRA through December 31, 2016; (4) accelerated vesting with respect to an aggregate of 40,613 restricted share units; (5) up to $100,000 worth of outplacement services; (6)
reimbursement of up to $710 per month for office expenses until the earliest of December 31, 2016 or the date Mr. Marchetti obtains other employment; and (7) payment of accrued vacation. Such amounts are reported in the All Other
Compensation for fiscal 2016 in the Summary Compensation Table.

We describe below transactions since the beginning of fiscal 2016 to which we were a party or will be a party, in which the
amounts involved exceeded or will exceed $120,000 and in which the following persons had or will have a direct or indirect material interest:



any of our directors or executive officers;



any nominee for election as one of our directors;



any person or entity that beneficially owns more than five percent of our outstanding shares; or



any member of the immediate family of any of the foregoing persons.

Employment of Family Members

George Mitchell, brother of David T. Mitchell, is Senior Vice President, Business Development and Corporate Quality. In
fiscal 2016, he received total cash compensation of $328,746 and perquisites in the amount of $135,795. George Mitchells current annual base salary is $300,000.

Sean Mitchell, son of David T. Mitchell, is a Program Manager at our Fabrinet West subsidiary. In fiscal 2016, he
received total cash compensation of $124,038 and perquisites in the amount of $1,055. Sean Mitchells current annual base salary is $125,000.

Dr. Soon Kaewchansilp, father-in-law of David T. Mitchell, is a member of the board of directors of our Thai subsidiary,
Fabrinet Co., Ltd. and was appointed in March 2015 as the first Fabrinet Fellow in recognition of his many years of exemplary service to the company. As a Fabrinet Fellow, Dr. Kaewchansilp will continue to serve as Fabrinets ambassador to
the Thai-American Chamber of Commerce, liaise with Thai government officials on behalf of Fabrinet, and mentor our employees in Thailand. In fiscal 2016, Dr. Kaewchansilp received total cash compensation of $180,000 and perquisites in the
amount of $24,836.
Dr. Kaewchansilp will receive a lump sum payment of $500,000 when his relationship with the company concludes.

Policy for Approval
of Related Party Transactions

In accordance with the Audit Committees charter, the Audit Committee reviews and
pre-approves in writing any proposed related party transactions. The most significant related party transactions, particularly those involving our directors and officers, will be reviewed and pre-approved in writing by our Board of Directors. We
will report all such material related party transactions under applicable accounting rules, federal securities laws and SEC rules and regulations. Any dealings with a related party must be conducted in such a way that does not give us or the related
party preferential treatment. For purposes of these procedures, related person and transaction have the meanings contained in Item 404 of Regulation S-K.

The following table sets forth information with respect to the beneficial ownership of our ordinary shares as of October 17,
2016, for:



each person (or group of affiliated persons) who is known by us to beneficially own more than 5% of our
ordinary shares;



each of our directors and director nominees;



each of our Named Officers; and



all of our directors and current executive officers as a group.

We have determined beneficial ownership in accordance with SEC rules. Except as indicated in the footnotes below, and
subject to applicable community property laws, we believe, based on the information furnished to us, the persons and entities named in the table below have sole voting and investment power with respect to all ordinary shares shown as beneficially
owned by them. Percentage of beneficial ownership is based on 36,778,321 ordinary shares outstanding as of October 17, 2016. In computing the number of ordinary shares beneficially owned by a person or entity and the percentage ownership
of that person or entity, we deemed to be outstanding all ordinary shares as to which such person or entity has the right to acquire within 60 days of October 17, 2016, through the exercise of any option or other right. We did not deem these
shares outstanding, however, for the purpose of computing the percentage ownership of any other person or entity.

Consists of (i) 901,649 shares held by the David T. Mitchell Separate Property Trust, of which Mr. Mitchell is
the sole trustee, (ii) 129,828 shares issuable upon the exercise of options held by Mr. Mitchell that are exercisable within 60 days of October 17, 2016, (iv) 75,680 shares held by the Gabriel Thomas Mitchell Trust, of which Kimberley Totah is the
sole trustee, (v) 75,681 shares held by the Alexander Thomas Mitchell Trust, of which Kimberley Totah is the sole trustee, and (vi) 75,680 shares held by the Sean Thomas Mitchell Trust, of which Kimberley Totah is the sole trustee. Mr. Mitchell
disclaims beneficial ownership of the shares held by each of the Gabriel Thomas Mitchell Trust, the Alexander Thomas Mitchell Trust and the Sean Thomas Mitchell Trust.

(4)

Consists of (i) 45,451 shares held by Mr. Ng, and (ii) 49,688 shares issuable upon the exercise of options
held by Mr. Ng that are exercisable within 60 days of October 17, 2016.

(5)

Mr. Marchetti left Fabrinet in December 2015. We have provided his ownership information based on the
last information known to us.

(6)

Consists of (i) 26,581 shares held by Mr. Kelly and (ii) 30,000 shares issuable upon the exercise of options
held by Mr. Kelly that are exercisable within 60 days of October 17, 2016.

(7)

Includes 209,516 shares issuable upon the exercise of options held by our current directors and executive
officers that are exercisable within 60 days of October 17, 2016.

Section 16(a) of the Exchange Act requires our directors, executive officers and any persons holding more than 10% of
a registered class of our equity securities to report initial ownership of such equity shares, and any subsequent changes in ownership to the SEC. Such officers, directors and 10% shareholders also are required by SEC rules to furnish us with
copies of all Section 16(a) forms they file. Specific due dates have been established by the SEC, and we are required to disclose in this proxy statement any failure to file required ownership reports by these dates. Based solely on our
review of copies of such forms received, or written representations from certain reporting persons that no filings were required for such persons, we believe that during fiscal 2016 all Section 16(a) filing requirements applicable to our executive
officers and directors were complied with, except as follows:



On August 18, 2015, Dr. Gill filed a late Form 4 to report 10,172 shares withheld to pay taxes upon the
vesting of restricted share units on August 9, 2015.



On August 18, 2015, Mr. Marchetti filed a late Form 4 to report 3,705 shares withheld to pay taxes upon the
vesting of restricted share units on August 9, 2015.

OTHER MATTERS

We know of no other matters to be submitted at the Annual Meeting. If any other matters properly come before the Annual
Meeting, it is the intention of the persons named in the enclosed proxy card to vote the shares they represent as our Board of Directors may recommend. Discretionary authority with respect to such other matters is granted by the execution of
the enclosed proxy.

It is important your shares be represented at the Annual Meeting, regardless of the number of shares
that you hold. You are, therefore, urged to vote by telephone, by using the Internet as instructed on the enclosed proxy card, or by executing and returning the enclosed proxy card in the envelope provided at your earliest convenience.

Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your
proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.

Electronic Delivery of Future PROXY MATERIALS

If
you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic
delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years.

VOTE BY PHONE - 1-800-690-6903

Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you
call and then follow the instructions.

VOTE BY MAIL

Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote
Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.

KEEP THIS PORTION FOR YOUR RECORDS

THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY

The Board of Directors recommends you vote FOR the following:

1. Election of Directors

Nominees

01 Dr. Homa Bahrami 02 Rollance E.
Olson

For Withhold For All

All All Except

To withhold authority to vote for
any individual nominee(s), mark For All Except and write the number(s) of the nominee(s) on the line below.

The Board of Directors recommends you vote FOR proposals 2. and 3.

2. Approval, on an advisory basis, of the compensation paid to Fabrinets named executive officers.

3. Ratification of the appointment of PricewaterhouseCoopers ABAS Ltd. as Fabrinets independent registered public accounting firm for the fiscal year ending June 30, 2017.

NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

Yes No

Please indicate if you plan to attend this meeting

Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other
fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer.

Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Proxy Statement & Annual Report is/are available at www.proxyvote.com

FABRINET

Annual Meeting of Shareholders

December 15, 2016 9:00 AM

This proxy is solicited by the Board of Directors

The undersigned shareholder of Fabrinet hereby appoints Colin R. Campbell and Toh-Seng Ng, and each of them, as proxies
and attorneys-in-fact, with full power to each of substitution, on behalf and in the name of the undersigned, to represent the undersigned at the 2016 Annual Meeting of Shareholders of Fabrinet to be held on December 15, 2016 at 9:00 a.m.,
Pacific time, at the offices of Wilson Sonsini Goodrich & Rosati, PC, located at 650 Page Mill Road, Palo Alto, California 94304, and at any adjournments or postponements thereof, and to vote all ordinary shares which the undersigned would
be entitled to vote if then and there personally present, on the matters set forth on the reverse side.

This
proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance with the Board of Directors recommendations indicated on the reverse side, and according to the
discretion of the proxy holders for any other matters that may properly come before the meeting or any postponement or adjournment thereof.